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My thesis has identified a subpopulation of inhibitory GABAergic neurons in the 
dorsolateral hypothalamus and zona incerta that express the LIM homeodomain 
transcription factor Lhx6, that are found in close proximity to wake-promoting 
hypocretin-expressing of the lateral hypothalamus (LH), which selectively degenerate in 
narcolepsy. Lhx6 is a master regulator of the development of GABAergic interneurons in 
telencephalic structures such as the cortex and hippocampus, but its function in the 
hypothalamus is unknown. Over the past several years, we have investigated the 
development and function of these neurons, and have found hypothalamic Lhx6-
expressing neurons do not migrate but require Lhx6 for their survival, and are activated 
by sleep pressure, directly inhibit wake-active hypocretin cells in the LH. Conditional 
deletion of Lhx6 from the developing diencephalon leads to decreases in both NREM and 
REM sleep.  Furthermore, selective activation and inhibition of Lhx6-positive zona 
incerta (ZI) neurons acutely and bidirectionally regulates sleep duration in adult animals.   
These studies identify a novel GABAergic subpopulation of ZI neurons that play a 
central role in promoting sleep. 
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1. Developmental characteristics of Lhx6 in telencephalon and diencephalon 
The research focus in my thesis is about the developmental and functional 
characteristics of hypothalamic Lhx6 neurons. I will start of introducing this specific 
marker, Lhx6, a transcription factor with its known functions in the brain.  
1.1 Lhx6 in telencephalon 
LIM domains,  which are now recognized as mediating selective protein-protein 
interaction, are known to be key components of the regulatory machinery in the cell [1]. 
There are approximately 55 amino acids with 8 highly conserved residues , mostly 
cysteine and histidine, comprising of individual LIM domains.  Recent analysis of LIM 
domains from many different species, including human beings, has identified a slightly 
broader consensus sequence than the classical LIM consensus sequence, orginally 
defined as CX2CX16–23HX2CX2CX2CX16–21CX2(C/H/D) (where X denotes any 
amino acid) [2] (Figure 1.1.1 a) [3]. The LIM domain contains two zinc ions,which are 
bound by the eight most highly conserved residues are the zinc-binding residues.  
Residues 1–4 coordinate with the first zinc ion, and residues 5–8 coordinate the second 
zinc ion, which establishes the tandem zinc-finger topology [4] illustrated in Figure. 1.1.1 
b. LIM domains are present in many proteins that have diverse cellular roles as regulators 
of gene expression, cytoarchitecture, cell adhesion, cell motility and signal transduction. 




in many neuronal processes during brain development, including cell fate specification, 
neuronal migration and connectivity [3,5]. 
Lhx6, a LIM homeodomain factor originally termed Lhx6.1 (Figure 1.1.2), was 
found in several restricted regions in the developing CNS, mostly within the embryonic 
telencephalon [6] and diencephalon.  Acting in part through LIM domain-medidated its 
protein-protein interaction function, Lhx6 may have a critical role in controlling cell 
differentiation and cell fate during development.  
 
Figure B1.1.1 The sequence and topology of the LIM domain (a) analysis of 135 human 
LIM sequences  showed eight zinc-binding residues (1–8) (b) zinc coordination. The zinc-
binding residues are shown as purple circles. The green spheres indicate semi-conserved 
aliphatic/bulky residues. The magenta spheres represent Non-conserved residues with 





Figure B1.1.2 Human Lhx6.1, and mouse Lhx6 with multiple amino acid sequence alignment. There is 
difference between deduced amino acid sequences of mouse (m) and human (h) Lhx6.1. Solid lines indicate 
two LIM domains. The homeodomain is represented by dashed line. [6] 
 
1.2 Lhx6 is required for the survival, migration and differentiation of GABAergic 
interneurons in the cerebral cortex 
Thus far, most studies of Lhx6 function have focused on its role in migration and 
differentiation of cortical GABAergic interneurons. In rodents, inhibitory GABAergic 
interneurons, which constitute 20~30% of cortical neurons, are an extremely 
heterogeneous cell population, which are composed of multiple subtypes that are broadly 
distributed, and which display different morphologies, electrophysiolological and 
molecular properties [7, 8, 9, 10]. In contrast to pyramidal neurons, which are born in the 
dorsal telencephalon, the majority of cortical GABAergic interneurons originate in the 
medial ganglionic eminence (MGE) and caudal ganglionic eminence (CGE) of the 
ventral forebrain, are generated between embryonic day 12.5 (E12.5) and birth, and reach 
the cortex by tangential migration [11,12, 13, 14, 15, 16,17,18, 19, 20].  The 
homeodomain transcription factors, Nkx2.1 and Lhx6 are known to play essential roles in 




interneuron development [21, 22, 23].  In addition, Nkx2.1 is a gene with both activator 
and repressor function.   By means of its repressor function, it can attenuate the 
expression of CGE-specific genes, while its activator function induces the expression of 
Lhx6 [24]. During cortical development, Lhx6 transcripts were detected in the 
subventricular and mantle zones of the MGE , while a small number of Lhx6-expressing 
cells were also found in the LGE, and represent the tangentially migrating population of 
cortical interneurons (Figure 1.2.1) [25]. 
 
Figure B1.2.1 Expression of the Lhx6/LacZins allele recapitulates the pattern of 
expression of the wild-type Lhx6 locus. Coronal sections from the forebrain of E12.5 (A, 





Cortical interneurons derived from MGE can be identified based on the 
expression of calcium-binding proteins parvalbumin (Pv), calbindin(Cb), calretinin(Cr) or 
the neuropeptide somatostatin (Sst) [26, 27, 28]. Nkx2.1 activates Lhx6, which in turn 
drives the expression of a series of factors including Sox6 and Satb1 whose actions 
selectively affect the development of both Pv- and Sst-expressing interneurons [29, 30].  
 
Figure B1.2.2 Lhx6 is expressed in the majority of Pv+ and Sst+ cortical interneurons. 
Confocal microscope images of cortical sections from Lhx6+/LacZins animals double 
immunostained for beta-gal and either Pv (A–C), or Sst (D–F ), or Cr (G–I ). As is 




coexpress beta-gal (C, F, arrows) but was generally excluded from neurons of bipolar 
morphology that expressed high levels of Cr (G–I, arrows)[25]. 
 
Lhx6 is preferentially expressed in mature Pv+ and Sst+ cortical interneurons [25] 
(Figure 1.2.2). Functionally, Lhx6 mutants exhibit many phenotypes, including severe 
reduction of the number of Sst+ and Pv+ cortical interneurons, slowed or even failed 
tangential migration, and abnormal neocortical laminar position of interneurons [31, 32].  
 
Figure B1.2.3 Lhx6 knockout leads to dramatic reduction in the number of Pv- and Sst-
expressing interneurons in the neocortex.  Sections  from the neocortex of 2-week-old 
animals heterozygous (A, C, E) or homozygous (B, D, F ) for Lhx6 deletion were showed 
for Pv (A, B) or Cr (E, F ) immunostaining or hybridized with an Sst-specific riboprobe 






Lhx6 is required for the specification of Pv+ and Sst+ cortical interneurons, while 
severe reduction in the number of Pv+ and Sst+ expressing interneurons was observed in 
Lhx6 null cortex (Figure 1.2.3). However, the effects are not only restricted to Pv+ and 
Sst+ cortical interneurons. Furthermore, Lhx6 deletion leaded to abnormal tangential 
migration of the great majority of cortical GABAergic interneurons (Figure 1.2.4) [25].  
   
Figure B1.2.4 Lhx6 mutant embryos showed delayed tangential migration and abnormal 
distribution of GABAergic interneurons in the cortex. A–D, In situ hybridization of 
coronal brain sections from E13.5 (A, B) and E15.5 (C, D) embryos compared 




Compared to controls, GAD67+ cells were restricted to the most ventrolateral region of 
E13.5 mutant cortex. [25] 
 
At E13.5, a large number of GABAergic cells were observed in the MGE and 
LGE (Figure 1.2.4 A control).  Tangentially migrating GAB67+ cells were located in a 
substantially more ventrolateral position in the  E13.5 Lhx6 mutant cortex (Figure 1.2.4 B 
mutant). At a later stage, E15.5, although most of GAB67+ cells were present in the 
lower intermediate and subventricular zones (IZ/SVZ), many remaining cells were found 
in the subplate of the lateral cortex, with the MZ and the cortical plate containing very 
few GAD67+ neurons (Figure 1.2.4 D).  
These data demonstrate the importance of Lhx6 in the development of cortical 
interneurons. However, Lhx6 is not required for the survival of the cortical interneurons, 
despitet the fact that they failed to migrate to the correct cortical laminar positions [25, 31, 
32]. In contrast to the role of Lhx6 in cortex and other telencephalic regions, Lhx6 is 
required for the survival of Lhx6 neurons in hypothalamus, which will be discussed in 
Chapter 2.  
 
1.3 Lhx6 in the developing hypothalamus 
The vertebrate hypothalamus is known as a central homeostatic regulator of 
innate behaviors within the neuroendocrine system with physiological processes that are 
essential for survival. A number of transcription factors have been identified previously 
as markers that regulate the development of specific hypothalamic nuclei and neuronal 
subtypes [33,34,35,36,37,38,39]. However, we still lack extensive knowledge of the 




entitled "A genomic atlas of mouse hypothalamic development ", in Nature Neuroscience 
[40]. In this paper our lab identified hypothalamic markers that labeled each major 
developing hypothalamic nucleus, and generated in situ hybridization for 1,045 genes 
through the entire course of hypothalamic neurogenesis. Based on these in situ results, 
our lab constructed a detailed molecular atlas for the developing hypothalamus from 
which the hypothalamus developing stages can be characterized by various groups of 
gene populations. Among all the genes identified in our lab work, Lhx family genes were 
found to delineate discrete regions of the developing hypothalamus. Two-color ISH with 
Lhx6 and the inhibitory interneuron marker Gad67 was conducted to characterize the cell 
types of the intrahypothalamic diagonal and tuberomamillary terminal. As will be shown 
in the Results (Chapter 1), Lhx6 and Gad67 expression fully overlapped at all stages of 
hypothalamic development. Other Lhx family members including Lhx9, Lhx8, Lhx1 
were also expressed in distinct domains in the intrahypothalamic diagonal (Figure 1.3.1) 
[40]. Lhx9 was found to be expressed immediately ventral to the Lhx6-positive zone of 
the intrahypothalamic diagonal (Figure 1.3.1a), and it has been reported that Lhx9 
colocalizes with hypocretin (Hcrt) and is both necessary and sufficient to specify Hcrt-
expressing neurons in the developing mouse and zebrafish hypothalamus (Figure 1.3.1 
c,f,i)[41, 42]. Lhx8 was expressed immediately anterior to the Lhx6-positive region of the 
intrahypothalamic diagonal (Figure 1.3.1 d), while anterodorsal to Lhx9 at E12.5 (Figure 
1.3.1g). The relative positions of each gene expression domain were maintained, even at 
E16.5 (Figure 1.3.1h). In adult, Lhx8 is expressed in dorsal medial hypothalamus, a 
region that has been reported to be important for feeding-dependent entrainment of 




of the suprachiasmatic nucleus [43, 44], was coexpressed with Lhx8 at E12.5, but at later 
stages was expressed in a more posterior, non-overlapping region (Figure 1.3.1h).  
 
Figure B1.3.1 Lhx family members delineate various regions of the developing 
hypothalamus and some of the markers coexpressed with Lhx family genes. Lhx gene 
expression patterns weres showed schematically at E12.5 and E16.5. (a,b) Lhx6 (blue)  
and Lhx9 expression (brown) were expressed in the posterior portion of the 
intrahypothalamic diagonal (a), which pattern was preserved at E16.5 (b). (d,e) Lhx8 
(blue) was found to be expressed anterior to the Lhx6-positive region (brown). (g,h) Lhx8 




(blue) expression region was anterior to Lhx9 and Lhx6 (brown), but overlapped with 
Lhx8. (c,f,i,m) Lhx6 overlapped with Cart. A conserved spatial relationship between Lhx9 
(purple) and Lhx6 (brown) was shown in lateral hypothalamus at P6. Lhx6-positive cells 
(brown) were found medial and dorsal to galanin (Gal)-positive neurons (purple) 
partically coexpress with Lhx9 (f). Lhx6-positive cells (brown) were found medial and 
dorsal to hypocretin (Hcrt)-positive neurons (blue) partically coexpress with Lhx9 (i). In 
dorsomedial hypothalamic nucleus Lhx8 (brown) was expressed medial to Cart (blue) 
(m). Lhx1 expression corresponded to the Rorα-positive SCN at E16.5 is located at the 
anterior terminus of the zone. Scale bar represents 0.2 mm (a, b, d, e, g, h, k and l) and 
0.3 mm (c, f, i, j, m and n). [40] 
 
These studies show that expression of Lhx family genes delinate a series of 
hypothalamic nuclei which reside both between and lateral to the paraventricular nucleus 
and VMH.  
In summary, Lhx6, a LIM homeodomain transcriptional factor family gene, is 
known to play a central role in various aspects of forebrain development, including 
tangential migration and differentiation of cortical GABAergic interneurons.  During 
embryonic development, multiple Lhx family genes are expressed in continuous zone 
within the hypothalamus. In hypothalamus, however, the function of Lhx6 is 
uncharacterized.  Identifying the function of Lhx6 in hypothalamus, and comparing this 
to its known function in cortical development, is a topic of considerable potential interest.   
2. Sleep/Wake cycle regulators in the hypothalamus and other brain regions 
A major focus of my thesis work it characterizing the behavioral functions of 
hypothalamic Lhx6-positive neurons. The hypothalamus is a key regulator of 
physiological homeostasis, including, but not limited to, regulating innate behaviors such 
as sleep, food intake, thermal regulation, and emotion. Discrete hypothalamic nuclei 




hypothalamic Lhx6 neurons was conducted as a part of my thesis research, and we found 
that hypothalamic Lhx6 neurons are differentially activated during the sleep/wake cycle. 
In order to to better detail the function of Lhx6-expressing neurons in the hypothalamus, I 
will introduce some background about neural circuitry that regulates the sleep/wake 
cycles.  
 
2.1 sleep/wake states switching networks 
Sleep is an innate behavior shared by virtually all animals, and is regulated by a 
complex and distributed network of sleep-promoting and wake-promoting neuronal 
subtypes [45]. Sleep/wake cycles can be roughly classified into three stages: wakefullness, 
rapid eye movement (REM) sleep and non-REM sleep, which can be clearly 
distinguished in rodents and human beings using electroencephalogram (EEG) and 
electromyogram (EMG) recordings. During non-REM sleep, the EEG exhibits a low-
frequency (0.5~4Hz) and high amplitude activity, while EMG activity is low.  On the 
other hand, REM sleep, which is the period during which vivid dreaming occurs, is 
characterized by high-frequency and low amplitude EEG activity, along with a complete 
paralysis of postural muscles without detectable EMG activity [46]. In contrast, the 
wakefulness stage is dominated by a high-frequency and low amplitude EEG activity as 
well as a high muscle tone as measured by EMG. Transition between sleep/wake states 
are associated with major changes in multiple physiological processes, including eye 
closure, breathing, arousability and muscle tone. The transition from wakefulness stage to 
non-REM sleep can take place over a few seconds or less in rodents, but may take 




it is typically mantained from three to five minutes in rodents, while in human beings it 
might last between 40 mins and 1 hour.  At the end of this bout, EEG activity begins to 
make another transition from non-REM sleep to REM sleep, a process which takes only a 
few seconds.  During REM sleep, there is a complete loss of muscle tone, except muscle 
activity for breathing and rapid eye movements. An individual might switch back and 
forth between non-REM and REM sleep with occasional transitions to wakefullness 
during sleep time. As a result,  sleep-wake transitions are rapid and bistable [49], 
regulated by mutual interactions between sleep-promoting and wake-promoting neurons 
(Figure 2.1.1). Cholinergic neurons located in the pedunculopontine and laterodorsal 
tegmental nuclei (PPT and LDT) at brainstem provide the main input from the 
mesopontine junction to the thalamus while monoaminergic and glutamatergic neurons 
within the same region send direct innervation to the hypothalamus, basal forebrain and 
cerebral cortex [50, 51] (Figure 2.1.1 a). Many neurons in the PPT and LDT are wake-
promoting since they are usually active during wakefulness and REM sleep [52, 53], 
suggesting they can promote cortical activation.  Orexin/hypocretin neurons in the lateral 
hypothalamus help boost this arousal pathway, and these neurons also send direct 
excitatory projections to the thalamus and cortex. A population of neurons in the 








Figure B2.1.1 sleep-wake transitions. (a) wake-promoting pathways from brainstem to 
hypothalamus, basal forebrain, thalamus and cerebral cortex. (b) sleep-promoting VLPO 
and MnPO inhibit components of arousal pathways from brainstem. (c) the ascending 
arousal systems can also inhibit VLPO. Abbreviations: DR, dorsal raphe nucleus 
(serotonin); LC, locus coeruleus (norepinephrine); LDT, laterodorsal tegmental nucleus 
(acetylcholine); PB, parabrachial nucleus (glutamate); PC, precoeruleus area 
(glutamate); PPT, pedunculopontine tegmental nucleus (acetylcholine); TMN, 
tuberomammillary nucleus (histamine); vPAG, ventral periaqueductal gray (dopamine).  
 
 
the inhibitory neurotransmitters GABA and galanin, have been identified as sleep-
promoting neurons that inhibit the components of the ascending arousal pathways in both 
hypothalamus and brainstem [54, 55] (Figure 2.1.1 b).   Sleep-active neurons in VLPO 
also receives mutual inhibition from arousal-promoting neuronal subpopulations, 
including the histamine neurons in the tuberomammillary nucleus (TMN), dorsal raphe 
nucleus and ventral periaqueductal gray matter (vlPAG), parabrachial nuclues and LC [56, 
57] (Figure 2.1.1 c). In short, this mutual inhibitory relationship between the arousal- and 
sleep-promoting systems can lead to rapid and complete transitions between waking and 
sleeping states by providing "flip-flop" switch conditions. This "flip-flop" term comes 
from electrical engineering which tried to explain the sharp transitions between two 
mutually opposed states [58].  However, this switch is stablized by hypocretin/orexin 
neurons in the lateral hypothalamus [59]. Activation of hypocretin/orexin neurons can 
trigger an animal to rapidly switch from sleep to wakefulness, and loss of orexins neurons 
or orexin neuropeptide leads to narcolepsy or cataplexy in both humans and other 
mammalian species [60, 61]. However, the activity of these hypocretin/orexin neurons 







Figure B2.1.2 a flip-flop model for sleep-wake switching. (a) during wakefullness, the 
wake-promoting monoaminergic nuclei inhibits sleep-promoting ventrolateral peoptic 
nucleus (VLPO) with reinforcement from hypocretin/orexin neurons in lateral 
hypothalamus. (b) during sleep, VLPO is inhibiting hypocretin/orexin neurons for 
stablizing the inhibition to monoaminergic nuclei which results in a stable and sharp 






2.2 Stabilization of sleep homeostasis in lateral hypothalamus. 
As described in previous section, hypocretin peptides are produced exclusively by 
a group of large neurons in the lateral hypothalamus [62, 63, 64].  The lateral 
hypothalamus (LH) plays a central role in control of sleep-wake cycles and contains 
several subtypes of wake-promoting neurons, the best characterized of which are 
glutamatergic hypocretin (Hcrt)-expressing neurons [65, 66]. Although several inhibitory 
neuronal subtypes have been found to be presynaptic to Hcrt neurons [67, 68], their 
physiological role in modifying Hcrt–dependent regulation of sleep remain unclear 





Figure B2.2.1 Local regulation on hypocretin/orexin neurons by other population of 
neurons.There are direct and indirect regulation by local transmitters on hcrt neurons, 
during which most of the inhibitory control comes from GABAergic neurons. [69] 
Hypocretin released by Hcrt neurons activates Hcrt autoreceptors, and can 
increase presynaptic glutamate release [70, 71] (Figure 2.2.1 A, B).  Reciprocal 
communications between hypocretin neurons and GABAergic neurons including melanin 
concentrating hormone  (MCH) neurons are important for sleep/wake regulation, and 




2.3 Functional characteristics of zona incerta 
The Lhx6 neurons that are the focus of this study are located in both the LH and 
the zona incerta.  The zona incerta (ZI), a highly heterogeneous structure located between 
the LH and the thalamic reticular nucleus, plays diverse roles in sensory-motor 
integration and sends efferent projections to multiple brain regions, including the cerebral 
cortex, central thalamus, LH and midbrain [76, 77]. Recent studies demonstrated that the 
ZI may regulate behavioral arousal through modulation of thalamocortical projections 
[78], and also modulate muscle paralysis seen during REM sleep [79]. Although the 
complete bilateral ablation of the ZI in rats does not affect sleep/wake cycles [80], the 
role of individual cell types within the ZI in controlling sleep is yet to be characterized. 
Lhx6 neurons express in the hypothalamus stretching from the ZI to posterior 
hypothalamus (PH) (see Chapter 1).   This study will focus on the molecular and 












All experimental animal procedures were approved by the Johns Hopkins 
University Institutional Animal Care and Use Committee. The BAC transgenic Lhx6-
eGFP mouse line was generated as part of the GENSAT project [81], and obtained from 
MMRRC (Stock Number: 000246).  Hcrt-eGFP transgenic mice were obtained from Luis 
de Lecea of Stanford University School of Medicine [82].  Lhx6-Cre mice were 
generously shared by Dr. Aryn Gittis of Carnegie Mellon University, and were originally 
generated by Dr. Nicoletta Kessaris of University College, London [83]. Lhx6-CreERT2 
knock-in mice were generated by Z. Josh Huang of Cold Spring Harbor Laboratories 
were purchased from The Jackson Laboratory (Stock Number: 010776) [84]. Foxd1-
CreEGFP knock-in mice [85] were obtained from Jackson Laboratories (Stock Number: 
012463).    
Lhx6lox/lox mice were obtained from Dr. Vassilis Pachnis from The Francis Crick 
Institute, London.   The conditional Lhx6 allele was generated via homologous 
recombination using a targeting construct in which loxP sites were placed in non-coding 
regions just 5’ to coding exon 1b, and 3’ to coding exon 3. The 5’ homology is made up 
from a 3.1 kb XbaI–SacI fragment containing the 5 upstream region and the first exon 
(1a) of Lhx6, whereas the 3’ homology is made up from a 5.4 kb ApaI–NheI fragment. 
For the Lhx6  targeting vector, the 2 kb genomic fragment between the homology regions 
is replaced by a 4 kb cassette, containing the following: (1) the 1b, 2 and 3 coding exons 




phosphoglycerate kinase (PGK) promoter (PGK-Neo) flanked by FRT sites. Targeting 
constructs were linearized and electroporated into E14Tg2A embryonic stem (ES) cells. 
Targeted clones were identified and analyzed in detail by Southern blotting using 5 and 3 
external probes. Germline transmission of the mutant alleles was achieved using standard 
protocols. The phenotypic analysis presented was performed on animals from which the 
PGK-Neo cassette was removed by crossing founder conditional Lhx6  animals with the 
ACTB::FlPe transgenic line [86]. For the maintenance of the Lhx6 colony, we performed 
PCR using the following primers: Lhx6flR:GGAGGCCCAAAGTTAGAACC 
Lhx6flF:CTCGAGTGCTCCGTGTGTC. 
 
Stereotaxic AAV injection and EEG/EMG implantation.  
AAV vectors were obtained from vector cores of the University of Pennsylvania 
(AAV9.EF1a.flex.hChR2-eYFP) [87] and University of North Carolina (AAV9- 
EF1a.flex.hM3Dq-mCherry; AAV9-EF1a.flex.hM4Di-mCherry) [88].  For bilateral 
stereotaxic injection of AAV into the zona incerta, adult male mice (2~4 months old) 
were anaesthetized with ketamine/xylazine (100μl of 100mg/ml ketamine, 20mg/ml 
xylazine) and placed in a stereotaxic frame. The head skin was incised to expose the skull 
and gently scrape away connective tissue.  After exposing the skull, bilateral 
craniotomies  (~1 mm diameter each) were made to allow virus delivery (600-800nl at 40 
nl/min).  Stereotaxic coordinates: AP=-1.54mm, L=0.55mm, DV=-4.8mm, according to 
the reference atlas of Paxinos and Franklin [88].  Skin covering the boreholes was sutured 




For EEG/EMG recordings, four-channel tethered EEG/EMG biosensors (Pinnacle 
Technology Inc.) were anchored onto the mouse skull.  The two front screws used for 
EEG1 signal recording were positioned at: AP: +2 mm, ML: ± 1.5 mm.  The two back 
screws used for EEG2 signal recording were positioned at: AP: -4 mm, ML: ±] 1.5 mm).  
With the same implant, two EMG antenna electrodes were inserted into the left and right 
neck muscles. The EEG/EMG recording implant was secured to mount on the mouse 
skull with dental cement.  In cases where EEG/EMG analysis of DREADD-injected mice 
was performed, this surgery was performed immediately following AAV injection. 
 
Sleep recordings (EEG/EMG recording).  
For all analysis of sleep behavior, after the mice were allowed a minimum of 10 
days recovery in a 12-hour LD cycle following EEG/EMG biosensor implantation. We 
used the Pinnacle Technology EEG/EMG tethered recording system for sleep behavior 
evaluation. Implanted mice were tethered to a X100 preamplifier (Pinnacle Technology) 
and were housed in a 12-h dark/12-h light cycle (lights on between 7:00 (Zeitgeber time: 
ZT0) and 19:00 (ZT12) recording chamber. The mice were allowed 5~7 days to 
acclimatize to the recording chamber before recording. The EEG and EMG signals were 
preamplified ×5,000 and digitized at 14 bits, and then recorded. Signal acquisition was 
obtained using the Sirena acquisition suite (Pinnacle Technology Inc.)  EEG/EMG traces 
were recorded for 48 hours for Lhx6 conditional knockout mice, and data from the 
second day extracted for analysis. For analysis of mice injected with AAV expressing 




injection as control compared to animals with Clozapine-N-oxide (CNO, Sigma-Aldrich; 
0.5 mg/kg in saline) intraperitoneal (IP) injection. The following injection protocol was 
used for analysis of all animals injected with AAV expressing flexed DREADDs: on Day 
1, we performed two consecutive saline injections at 12 hr intervals at ZT23 (6am) and 
ZT11 (6pm); on Day 2, we injected CNO at ZT23 and ZT11; alternatively, on Day 1, the 
saline was injected at ZT5 and ZT17, similar to the timing of the CNO injection on Day 
2. 
   To validate the specificity and efficacy of AAV DREADD infection, following 
the termination of behavioral analysis, mice were given a single injection of CNO (0.5 
mg/kg in saline) and sacrificed 1hr later by terminal anesthesia and transcardiac 
perfusion.  Immunohistochemistry was then performed to detect both mCherry and c-fos 
expression. 
 
EEG/EMG analysis.  
Raw EEG/EMG signals were loaded into Neuroscore (DSI) for scoring. We set 
the high pass filter at 0.5 Hz and the low pass filter at 40Hz for both EEG channels. EMG 
signals were high pass filtered at 10 Hz and low pass filtered at 100Hz. EEG1 and EEG2 
signals were further transformed to be temporal AR (autoregressive model) spectrums. 
Researchers were blinded as to genotype and/or treatment condition prior to data 
analysis. Sleep/wake state was visually scored by ~10 second epochs as either wake (low-
voltage, high frequency EEG wave with high activity of EMG), rapid eye movement 




(NREM, high-voltage, low frequency EEG wave with low activity of EMG). The 
percentage of time spent in each behavioral state was then statistically evaluated. 
For investigating the sleep/wake behavior of Lhx6 cKO mice, the EEG/EMG 
analysis was conducted for 24 hours for both control and Lhx6 cKO groups. In our 
analysis of sleep/wake behavior in mice expressing activating or silencing DREADDs, 
we analyzed data for 12 hours after either saline or CNO injection, as effects of CNO 
were not observed at longer than 10 hours post-injection.  A 2-hour accumulation 
analysis was also conducted for evaluating temporal dynamics of sleep/wake states. 
For spectral band analysis, we applied fast Fourier transform (FFT) to 5 second 
epochs of raw EEG waves of non-REM stage to calculate EEG power frequency within 
the frequency range of 0.1~125 Hz.   Based on the sleep/wake stage labeling, we 
extracted a 2 hour period raw EEG wave of non-REM stage between 2 and 4 hours after 
injection of saline or CNO at ZT5 for EEG power spectrum analysis to evaluate the effect 
of activating or silencing Lhx6 ZI neurons. The EEG spectrum of the same time period 
(ZT7-ZT9) was also analyzed for the Lhx6 cKO mice. Artifacts were removed from 
analysis by visual inspection of raw EEG and EMG data, we manually removed the data 
epochs with noise associated with large movements (EMG muscle artifacts) that occurred 
during active wake and vigilance states, which cover ~10% of the recording interval.  
Movements were confirmed by analysis of videotape.  In addition, a low-rank 
approximation was applied to remove the smaller Eigen factors from the raw data, and 
similar results were obtained to those seen using manual removal of artifacts. The 
frequency data was collapsed into 0.5 Hz bins. We standardized the frequency data by 




time of a different day. The standardized frequency data were then averaged among each 
group of mice. To analyze the EEG frequency bands, relative power bins were summed 
as such: δ 0.5-4 Hz, low θ 4-6 Hz, high θ 6-10 α 10-20 Hz, β 20-40 Hz and  40-100 Hz.   
All the frequency bins and bands analyses were done using custom pipelines written 
using Matlab (MathWorks). 
 
Behavioral analysis of Lhx6 cKO mice.   
We conducted several behavioral tests to investigate the phenotype of Lhx6 cKO 
mice. These include: 
Light-dark preference test. Each mouse was placed in an apparatus consists of a 
dark chamber and a light illuminated chamber. Mice can move freely between the two 
chambers. The duration of time each the mouse spent in dark chamber, light chamber or 
center were measured and normalized relative to the the whole experimental period.  
Elevated plus maze (EPM) test.  Each mouse was placed in the center of the EPM 
and videotaped for 5 min. Time spent in open and closed arms were determined from the 
video recording by blinded observers.  
Open field test. Mice were placed in mice in the open field chamber and time 
spent in center and periphery was assessed for 30 min, using a Photobeam activity system 
to measure beam breaks.   
Rotarod.  Up to four mice were run at one time on a rotating rod that has the 




used to record when the animal dropped off of the rod as rotation speed gradually 
increased.  Average terminal rotation speed and time spent on the Rotarod was used for 
analysis.   
Grip strength. Forelimb grip strength is measured as tension force using a 
computerized grip strength meter (GSM).  Mice were lifted over the baseplate by their 
tails, and their forepaws allowed to grasp the steel grip. The tail of the each mouse was 
then placed in the center of the Single Axis Grip Strength Alignment Tool (SAGSAT), 
and the mouse is then gently pulled backward by the tail until its grip is released. The 
GSM is then used measure the maximal force before the mouse releases the bar. Three 
trials are performed for each mouse with a 1-minute resting period between trials. 
 
Electrophysiological characterization of Lhx6 neurons and postsynaptic targeting 
on Hcrt neurons using optogenetics.  
P25-P31 Lhx6-Cre;Hpcr-GFP or Lhx6-CreERT2;Lhx6-GFP mice were 
anesthetized with ketamine (50 mg/kg), dexmedetomidine (25 μm/kg) and the inhalation 
anesthetic, isoflurane (1-3%), and fixed in a custom-made stereotaxic frame. A small burr 
holes was made on skull, and 50-100 nl of AAV9-EF1α-hChR2(H134R)-mCherry viral 
vector (obtained from the University of Pennsylvania Vector Core) was pressure-injected 
into the zona incerta (AP=-1.35 mm, L=0.3 mm lateral, and DV=-4.7 mm) through a 
glass pipet (15-20 μm tip diameter, Drummond). The analgesic, buprenorphine (0.05 
mg/kg), was administered to all mice post-operatively. Mice were sacrificed 11-18 days 





Brain slice preparation and cell identification.  
Mice were anesthetized with isoflurane, decapitated, and the brains were rapidly 
removed and chilled in ice-cold sucrose solution containing (in mM): 76 NaCl, 25 
NaHCO3, 25 glucose, 75 sucrose, 2.5 KCl, 1.25 NaH2PO4, 0.5 CaCl2, and 7 MgSO4; pH 
7.3. Acute brain slices (300 μm) were prepared in a coronal orientation using a vibratome 
(VT-1200s, Leica). Slices were then incubated in warm (32-35°C) sucrose solution for 30 
minutes and then transferred to warm (32-34°C) artificial cerebrospinal fluid (aCSF) 
composed of (in mM): 125 NaCl, 26 NaHCO3, 2.5 KCl, 1.25 NaH2PO4, 1 MgSO4-7H2O, 
20 D-(+)-glucose, 2 CaCl2-2H2O, 0.4 ascorbic acid, 2 pyruvic acid, and 4 L-(+)-lactic 
acid; pH 7.3, 315 mOsm, and allowed to cool to room temperature. All solutions were 
continuously bubbled with 95% O2/5% CO2. 
For whole-cell recordings, slices were transferred to a submersion chamber on an 
upright microscope (Zeiss AxioExaminer, Objectives: 5x, 0.16 NA and 40x, 1.0 NA) 
fitted for infrared differential interference contrast (DIC) and fluorescence microscopy. 
Slices were continuously superfused (2-4 ml/min) with warm oxygenated aCSF (32-
34°C). Neurons were visualized with a digital camera (Sensicam QE; Cooke) using either 
transmitted light or epifluorescence. Hcrt neurons in Lhx6-Cre;Hcrt-GFP mice were 
identified based on their GFP expression. In Lhx6-CreERT2;Lhx6-GFP mice, Lhx6 
neurons were categorized as either virus-infected, ChR2-expressing Lhx6 cells or 
uninfected cells based on the viral gene, mCherry expression and current response to 1s 





Whole-cell recordings and analysis.  
Glass recording electrodes (2-4 MΩ) were filled with an internal solution 
containing (in mM): 36.4 KCl, 96.4 KMeSO3, 9.1 HEPES, 0.18 EGTA, 4 MgATP, 0.3 
NaGTP, 20 phosphocreatine(Na), pH 7.3, 295 mOsm. Biocytin (0.25% weight/volume) 
was added to the internal solution. Whole-cell patch clamp recordings were obtained 
using Multiclamp 700B amplifiers (Molecular Devices) and digitized using an ITC-18 
(Instrutech) controlled by custom software written in Igor Pro (Wavemetrics). The series 
resistance averaged 11.8 ± 4.4 MΩ SD (n = 39 neurons from 7 mice, all <30 MΩ) and 
was not compensated. For ChR2 photoactivation, a small circle (315 µm diameter) of 
blue light (6–600 mW/mm2) was delivered through the 40x objective lens using a fiber 
optic cable (920 µm diameter; Thorlabs) coupled to a blue LED (~470 nm; Luminous), 
and focused onto the recorded cell. To test GABAergic input onto the recorded neurons, 
cells were first washed in blockers of glutamate receptors, 5 µM 2,3-Dioxo-6-nitro-
1,2,3,4-tetrahydrobenzo[f]quinoxaline-7-sulfonamide disodium salt (NBQX; AMPA 
receptor antagonist) and 5 µM (RS)-3-(2-Carboxypiperazin-4-yl)-propyl-1-phosphonic 
acid (CPP; NMDA receptor antagonist), and then washed in blockers of both glutamate 
receptors and GABA receptors, including 10 µM 6-Imino-3-(4-methoxyphenyl)-1(6H)-
pyridazinebutanoic acid hydrobromide (SR95531; GABAA receptor antagonist, all from 
Tocris). The resting membrane potential was measured after whole-cell configuration 
was achieved. Neurons exhibiting a resting membrane potential greater than -60 mV were 




voltage change in response to a 1 s hyperpolarizing current step (-10 to -25 pA). All 
signals were low-pass filtered at 10 kHz and sampled at 20-100 kHz. 
Data analysis was performed in Igor Pro (Wavemetrics), Excel (Microsoft), and 
SigmaPlot (Systat Software). Data are presented as the mean ± SEM unless otherwise 
noted.  
  
Immunohistochemistry (IHC).  
Mice were anaesthetized with ketamine and transcardially perfused with 20mL 
1X PBS followed by 50mL of 4% paraformaldehyde (m/v) in PBS.  Brains were 
removed, fixed overnight in 4% paraformaldehyde, followed by 30% sucrose (m/v) in 
PBS overnight in 4°C for cryoprotection, and embedded and frozen in -80°C.  Using a 
cryostat, the frozen brains were sectioned into 40 μm coronal slices for 
immunohistochemistry. Immunohistochemistry was performed as described previously 
with minor changes [89].  Brain sections were washed with 1x PBS and incubated with 
Superblock (Thermo Scientific, Cat: 37515) to block non-specific binding site. After 
brief washing, primary antibodies were diluted in a blocking solution of 5% horse serum 
in 0.25% Triton X-100 in PBS.  The following primary antibodies were used: rabbit anti-
GFP (1:500;A-6455, Invitrogen); mouse anti-Lhx6 (1:100; sc-271433(Clone A-9), Santa 
Cruz Biotechnology), goat anti-HRCT (1:400; sc-8070, Santa Cruz Biotechnology), 
rabbit anti-cFos (1:400; sc-52, Santa Cruz Biotechnology), rabbit anti-tyrosine 
hydroxylase(TH) (1:400; p4010-150, Pel-Freez), rabbit anti-parvalbumin(1:400; PV 27, 




overnight at 4°C. Secondary antibody in blocking solution was then used to incubate the 
slides for 2 hr at room temperature. Secondary antibodies used were as following: Alexa 
Fluor 488 conjugated donkey anti Rabbit (1:500; A21206, Invitrogen); Alexa Fluor 488 
conjugated donkey anti mouse (1:500; A212062 Invitrogen); Alexa Fluor 488 conjugated 
donkey anti Goat (1:500; A11055, Invitrogen); Alexa Fluor 594 conjugated donkey anti 
Rabbit (1:500; A21207, Invitrogen); Alexa Fluor 594 conjugated donkey anti mouse 
(1:500; A21203, Invitrogen); Alexa Fluor 594 conjugated donkey anti Goat (1:500; 
A11058, Invitrogen). After washing in 0.1% Triton X-100 in 1X PBS and staining for 
DAPI (1:5000; 10236276001, Roche), brain sections were mounted on positively charged 
slides with Vectashield Mounting medium (H-1500, Vector laboratories). Fluorescent 
images were taken using a Zeiss Axioskop 2 Mot Plus Microscope or Zeiss Meta 510 
LSM confocal microscope. 
 
Quantification of c-fos expressing cells. 
To characterize ZI Lhx6 neurons activated under different lighting conditions, 
adult Lhx6-eGFP mice (2~4 months old) were deeply anaesthetized with ketamine at four 
time points across the light-dark cycle: 7AM (ZT0);1PM(ZT6);9PM (ZT14- lights off); 
1AM (ZT18 ). For the 7am time point, mice were anesthetized a few minutes before 
lights on with minimal light exposure. All other mice were anaesthetized within 15 
minutes of their time point group. Immediately after anesthesia, mice were transcardially 
perfused with 20mL 1X PBS followed by 4% paraformaldehyde (m/v) in 1X PBS. For 




months old) were sleep-deprived starting at 7AM (ZT0), until 1PM for a total of 6 hours. 
To facilitate sleep deprivation, mice were monitored in new cages with new beddings, 
given water and food ad libitum, and occasionally touched gently with a soft brush when 
they seemed drowsy, as described [89]. Control mice were not disturbed and allowed to 
sleep freely. Mice in the Sleep Deprivation group and control group were anesthetized at 
1pm and transcardially perfused and stained according to the protocol for 
Immunohistochemistry. Mice in the Sleep Deprivation with Recovery Sleep group were 
permitted to sleep at 1pm for 1h and then perfused at 2pm. All cell counting was 
conducted blind on 3x2 tiled images of the ZI using ImageJ. The area used for counting 
was demarcated by the Lhx6 cells in the ZI labeled by Lhx6-eGFP. For each animal, 4 
brain sections were analyzed bilaterally, and the percentage of cFOS-positive neurons in 
Lhx6-eGFP positive neurons was compared by nonparametric statistical methods (see 
Statistics).  
 
Fluorescent In Situ Hybridization (FISH) with Immunohistochemistry (IHC).  
We performed FISH staining on Lhx6-EGFP mouse with in situ markers 
including Gad1, somatostatin (Sst) and Npy. The RNA probes were generated using the 
following EST sequences as templates: Gad1 (GenBank accession #AI845043), Sst 
(GenBank accession #AI848192), Npy (GenBank accession #AI848386). Brains were 
removed from transgenic Lhx6-eGFP mice within 5 minutes after euthanasia and fixed 
overnight in 4% paraformaldehyde (m/v) in PBS at 4°C followed by incubation in 30% 




brains were sectioned into 40 μm using a cryostat and then mounted onto positively 
charged slides. For in situ hybridization, all equipment was cleaned with 0.3M Sodium 
hydroxide and RNAaseZap and all solutions were DEPC-treated and autoclaved.   
In situ hybridization follows as previously described [90] with some alterations. 
Briefly, slides are fixed in 4% paraformaldehyde (m/v) in 1X PBS for 15 minutes and 
then cell membranes are digested by incubation in 1μg/mL Proteinase K with 50 mM Tris 
pH 7.5 and 5mM EDTA in 1X PBS for 15 minutes. After re-fixation in 4% 
paraformaldehyde, the brain sections undergo acetylation with 0.27% acetic anhydride 
and 10% 1M TEA (pH 8) in 1X PBS. The slides are then washed in 1X PBS, incubated in 
0.1% Triton X-100 in PBS for 1h and then quenched in 1% hydrogen peroxide in PBS for 
30 minutes to eliminate endogenous peroxidase activity. Next, the slides are incubated in 
hybridization buffer (50% formamide, 5X SSC) for two hours and then incubated 
overnight under siliconized coverslips in Heat activated DIG-conjugated RNA probes 
diluted in hybridization buffer at 68°C. The next day, a 5X SSC (saline sodium citrate) 
wash was followed by two 0.2X SSC washes to remove the coverslips and to eliminate 
nonspecific probe binding.  The slides were then washed with 0.3% Triton X-100 in PBS 
and incubated in blocking buffer (0.1 Triton X-100, 1% HISS in 1x PBS) for 1h.  For 
detection of the Lhx6, IHC for anti-eGFP was combined with the subsequent in situ 
hybridization steps. The slides are incubated overnight at 4°C in a blocking solution 
containing rabbit anti-GFP antibody (1:500; A-6455, Invitrogen) and Anti-Digoxigenin-
POD antibody (1:1000; 1207733, Roche).  After washing the slides in 0.3% Triton-X 100 
multiple times on the third day, probe signal was recovered by Cy3-tyramide 




PerkinElmer) in 1X amplification diluent and monitored frequently by fluorescent 
microscopy for the timing of signal appearance. Slides were washed, quenched in 1% 
hydrogen peroxide and 0.3% Triton-X 100 in PBS, and blocked in blocking solution 
(0.2% Triton X-100, 1% Horse Serum, 0.1% BSA powder) for 1h.  Primary antibody 
signal is then detected by species specific Alexa fluorophores in Alexa Fluor 488 
conjugated donkey anti Rabbit (1:500; A21206, Invitrogen); incubated with blocking 
solution for 2h. Slides were then washed and coverslipped in Vectashield. Fluorescent 
images were taken using a Zeiss Axioskop 2 Mot Plus Microscope or Zeiss Meta 510 
LSM confocal microscope. 
Statistics.  
For c-fos immunohistochemistry analysis, each group contained data 3~4 mice, 
with a total of bilateral sides of 4 brain slices analyzed for each mouse, which resulted in 
inter-dependence in each group. As a result, to analyze this data, we applied linear 
mixed-effect model fit by REML, a nonparametric method. Two-tailed, one-way 
ANOVA was applied to evaluate the difference among multiple groups. Shapiro-Wilk 
Normality Test was used to test normal distribution of data in electrophysiological whole-
cell recordings, and paired t-test was used to test statistical significance before and after 
GABAA receptor antagonist treatment in ChR2 photostimulation experiment. All the 
sleep/wake data analysis was primarily performed by two-tailed paired t-test, and later 
confirmed by nonparametric method, Wilcoxon-Mann- Whitney test. The statistics were 






Chapter 1. Expression pattern of Lhx6 in hypothalamus 
morphology of hypothalamic Lhx6-positive neurons 
 
1.1 Expression of Lhx6 in Zona incerta (ZI) and its neuronal morphology 
To fully characterize the expression pattern of Lhx6 in the adult hypothalamus, 
we used a GENSAT BAC eGFP transgenic line [81] that faithfully recapitulated the 
endogenous expression pattern of Lhx6 in both telencephalon and diencephalon (97.8% 
of eGFP+ cells are Lhx6+).  In the diencephalon, Lhx6 was selectively expressed in a 
subset of cells in a contiguous zone that stretched from the ventral ZI, through the 
dorsomedial hypothalamic nucleus (DMH) and the lateral hypothalamus (LH), the 
posterior hypothalamus (PH) and ultimately to the premammillary bodies as previously 
described in the embryonic and early postnatal brain [40]. Figure 1.1.1 shows the 
expression pattern of Lhx6 in ZI. The morphology of ZI Lhx6-expressing neurons are 
mostly bipolar (Figure 1.1.1) with two long-range processes stretching along the ZI 
region.  These large neurons are likely the source of the long-range projections we 
observe to amygdala, midbrain and brainstem (see Chapter 3.3). These ZI Lhx6-




described further in Chapter 2.
 
Figure 1.1.1 (a) Schematics showing the distribution of Lhx6+ neurons across the 
rostrocaudal axis of the diencephalon. Red boxes indicate schematic distribution of 
Lhx6+ neurons (green) in the zona incerta (ZI). Co-expression of eGFP (green) in Lhx6-




cytoplasm, while Lhx6 immunostaining is nuclear.  Magnified images of b are shown in 
b1.  
 
1.2 Expression of Lhx6 in the dorsomedial hypothalamus (DMH) and its neuronal 
morphology 
The domain of Lhx6 expression in the hypothalamus forms a continuous zone 
along the anterior-posterior axis from ZI to PH. When Lhx6 merges from lateral ZI to 
DMH, the pattern and morphology of the DMH Lhx6-expressing neurons chages, as 
shown in Figure 1.2.1 The other markers that are co-expressed with the DMH Lhx6-
expressing neurons will be discussed in more detail in Chapter 2. 1 
 
1.3 Expression of Lhx6 in the posterior hypothalamus (PH) and its neuronal 
morphology 
Similar to the DMH, Lhx6-expressing neurons in the PH resemble small stellate 
cells, and also co-express GABAergic markers (Figure 1.3.1).  
 
1.4 Summary 
In summary, unlike Lhx6-expressing neurons in the cortex, Lhx6-expressing 
neurons in the hypothalamus form a continuous and previously uncharacterized domain, 
which extends from  the ZI to the PH and the premammillary nucleus, with a scattered 
subset found in the DMH. Furthermore, the morphology of Lhx6-expressing neurons 




subclasses of Lhx6-expressing neurons exist in the hypothalamus, a finding which will be 
described in more detail in Chapter 2. So far, no studies have characterized either the 
development or function of hypothalamic Lhx6-expressing neurons.  In the next chapter, 
I will discuss the developmental characteristics of hypothalamic Lhx6-expressing 
neurons, and describe how hypothalamic Lhx6-expressing neurons differ from cortical 






Figure 1.2.1 (upper) Schematics showing the distribution of Lhx6+ neurons across the 
rostrocaudal axis of the diencephalon. Red boxes indicate schematic distribution of 
Lhx6+ neurons (green) in the dorsal medial hypothalamus(DMH). Co-expression of 
eGFP (green) in Lhx6-eGFP line with Lhx6 immunostaining (red) in the DMH (c). GFP 
signal fills the cell cytoplasm, while Lhx6 immunostaining is nuclear.  Magnified images 





Figure 1.3.1 (upper) Schematics showing the distribution of Lhx6+ neurons across the 
rostrocaudal axis of the diencephalon. Red boxes indicate schematic distribution of 
Lhx6+ neurons (green) in the posterior hypothalamus(PH). Co-expression of eGFP 
(green) in Lhx6-eGFP line with Lhx6 immunostaining (red) in the PH (c). GFP signal 
fills the cell cytoplasm, while Lhx6 immunostaining is nuclear.  Magnified images of b 




Chapter 2. Heterogeneity of hypothalamic Lhx6-
expressing neurons 
One critical way to study a uncharacterised population of neurons in the brain 
region is to screen out multiple gene expression in this population, which can tell you 
about potential framework of its neuronal development and physiological functions. This 
is especially true in the hypothalamus, where most if not all neuronal populations are 
associated with innate behavior regulation.  Furthermore, different cell types can be 
classified based on the expression pattern of specific transcription factors, 
neurotransmitters and neuropeptides. We identified the LIM homeodomain transcription 
factor as a marker of a previously uncharacterized neuronal subpopulation that is 
distributed broadly across the posterior and lateral hypothalamus. In addition, we were 
looking for other molecular markers which define hypothalamic Lhx6-expressing 
neurons more clearly, and can provide us with the potential developmental characteristics 
and behavioral functions of hypothalamic Lhx6-expressing neurons. In this chapter, we 
applied RNA-Seq analysis to analyze hypothalamic Lhx6-expressing neurons, and used 
histological methods to co-localize other markers with Lhx6 in the hypothalamus.  
 
2.1 RNA-Sequence analysis of hypothalamic Lhx6-expressing neurons  
For RNA-Seq analysis, we used the GENSAT BAC eGFP transgenic line (Lhx6-
EGFP mouse), which faithfully recapitulated the endogenous expression pattern of Lhx6 




offspring and dissected out the hypothalamus and the cortical region separately. We then 
dissociated tissues using the protocol of Worthington papain dissociation kit [91]. The 
dissociated cells were then transferred to the Fluorescence-activated cell sorting (FACS) 
facility at the Johns Hopkins School of Public Health to collect Lhx6-EGFP neurons from 
the hypothalamus and the cortex. FACS allowed us to separate hypothalamic Lhx6-
expressing neurons into two groups, one with higher and one with lower GFP expression. 
This reflects the fact that hypothalamic Lhx6-expressing neurons are heterogenous. 
Lhx6-expressing neurons located at the ZI and the PH represent at least two subsets of 
neurons. The analysis of dissociated cells are shown in Figure 2.1.1, and reveals two 





Figure 2.1.1. (lower left) the dissociated cells from hypothalamus tissues. (upper 
right)FACSorted Lhx6-EGFP cells with lower GFP expression. (lower right) FACSorted 
Lhx6-EGFP cells with higher GFP expression. 
 
After FACS, we extracted RNA from both dissociated Lhx6-positive cells and 
Lhx6-negative cells (as control) in the hypothalamus and the cortex using the QIAGEN 
RNA extraction kit. Extracted samples were submitted for RNA-Seq analysis of Lhx6-
positive or Lhx6-negative neurons. Here in Figure 2.1.2, I show an example of RNA-Seq 
analysis from hypothalamic Lhx6-exressing neurons with high GFP expression. The first 
column lists individual genes. The second column shows the expression level of GFP- 
positive cells, while the 3rd column shows the expression level of GFP-negative cells.  
As we expected, Lhx6 is highly enriched in the hypothalamic GFP-positive cells, 
demonstrating  the specificity of the transgene and the efficiency of the sorting. All the 
other genes listed here are markers that are expressed in specific hypothalamic nuclei, but 
not enriched in hypothalamic Lhx6-expressing neurons.  These include Ghrh (expressed 
in the arcuate nucleus), Oxt (expressed in PvN/SON), and Olig1 (expressed in 
oligodendrocytes). This indicates the hypothalamic Lhx6-expressing cells are distinct 





Figure 2.1.2. Example of Deep RNA-sequencing analysis for hypothalamic Lhx6-EGFP 
neurons. The GFP+ FPKM column indicates the expression level of hypothalamic Lhx6 
GFP positive cells, against the GFP- FPGM column which shows the hypothalamic GFP 
negative cell gene expression level. q-value in log2(fold change) column indicates from 
statistic if there is a significant difference .  
 
Somatostatin (Sst), NPY , the markers of interneurons [92], are also enriched in 
the hypothalamic Lhx6-expressing neurons. However, our later histological identification 
demonstrated that both Sst and NPY were just intermingled with hypothalamic Lhx6-
expressing neurons but not colocalized.  
Figure 2.1.2 shows the analysis of hypothalamus Lhx6-expressing neurons with 
high GFP expression versus GFP-negative cells. Each dot represents one gene. In this 
figure,  the X-axis shows gene expression level of hypothalamus Lhx6-expressing 
neurons with high GFP expression, and Y-axis shows same gene expression level in 




one shows the higher level of gene expression in GFP-positive cells than GFP-negative 
cells, while the left cluster shows the opposite distribution.  Arx, Lmo3, ErbB4 
enrichment in Lhx6-positive cells indicates a possible role of Lhx6 in maturation and/or 
development of hypothalamic neurons.  Other genes enriched in Lhx6-positive cells 
include glutamate receptors and calcium channels.  Corticotrophin-releasing hormone 
(CRH) is enriched in a subset of Lhx6-expressing neurons.  Aromatase, also known as 
estrogen synthetase or estrogen synthase, is an enzyme responsible for biosynthesis of 
estrogens. Specifically, aromatase is responsible for the aromatization of androgens into 





Figure 2.1.3. Gene expression level comparison between P1 hypothalamic Lhx6-positive 
cells(x axis) and hypothalamic Lhx6-negative cells(y axis). The right cluster of blue dots 
showed are the genes enriched in Lhx6+ cells, while the left cluster are the genes not 
enriched in Lhx6+ cells.  
 
2.2 RNA-Seq of hypothalamic Lhx6-expressing neurons compared to telencephalic 
Lhx6-expressing neurons.  
We have also run RNA-Seq on cortical Lhx6-expressing neurons.  Hypothalamic 
and cortical Lhx6-expressing neurons share some of the same gene patterns, but there are 
also substantial differencse between them, implying that Lhx6 may have different 
developmental and functional roles in these two brain regions. Figure 2.2.1 shows the 






Figure 2.2.1. Comparison of gene expression pattern between hypothalamic Lhx6 and 
cortical Lhx6 neurons. The left panel showed in cortex the transcription factor expression 
profiles throughout specification, migration and differentiation of cortical interneurons 
deriving from the medial ganglionic eminence (MGE). The right panel showed part of the 
gene list which were enriched in both hypothalamic Lhx6 and cortical lhx6 neurons. 
 
Both hypothalamic and cortical Lhx6-expressing neurons express similar 
transcription factors such as Dlx family members and Arx.  They also express similar 
genes involved in, GABA syntheisis, synaptic GABA transport, and a number of 
neuropepties such as Npy. However, hypothalamic Lhx6 neurons selectively expressed a 
number of other genes, including the neuropeptides Nts and Penk, along with the 
calcitonin receptor Calcr.  The expresion profile in Lhx6-expressing neurons between two 
brain regions as shown in Figure 2.2.2. There are 206 genes that are enriched in Lhx6-
positive neurons (>2-fold elevated relative to Lhx6-negative neurons) and shared by both 
Lhx6 -expressing neurons in the hypothalamus and the cortex, while 102 genes are 





Figure 2.2.2. Gene expression level comparison between P1 hypothalamic Lhx6-positive 
cells(x axis) and cortical Lhx6-positive cells(y axis). The right cluster of blue dots showed 
are the genes enriched in hypothalamic Lhx6+ cells, while the left cluster are the genes 
enriched in cortical Lhx6+ cells.   
 
2.3 Zona incerta Lhx6-expressing neurons co-express GABAergic marker 
This RNA-Seq data revealted that hypothalamic Lhx6-expressing cells co-express 
markers of GABAergic neurons, including Gad1 and the vesicular GABA transporter 
Slc32a1 (Figure 2.3.1 and Figure 2.3.2 i-l).  Lhx6 is expressed in ~70% of cortical 
interneurons, and is essential for specification of parvalbumin (Pvalb) and somatostatin 
(Sst)-expressing neurons in the cortex [25]. In sharp contrast to telencephalic Lhx6-
expressing neurons, we have failed to observe substantial colocalization of diencephalic 




hypothalamus (Figure 2.3.2 a-h).  
 
 
Figure 2.3.1. Lhx6-expressing neurons in the zona incerta are GABAergic (a) Schematics 
showing the distribution of Lhx6+ neurons across the rostrocaudal axis of the 
diencephalon. Red boxes indicate schematic distribution of Lhx6+ neurons (green) in the 
zona incerta (ZI), with representative images of the ZI shown in (b). (b) Co-expression of 
eGFP (green) in Lhx6-eGFP line with Lhx6 immunostaining (red) in the ZI. GFP signal 
fills the cell cytoplasm, while Lhx6 immunostaining is nuclear.  Magnified image of b is 
shown in b1. Scale bar = 100 μm. (c) A bar graph on the left (blue) showing the 
percentage Lhx6-immunostained neurons and TdTom expression in the Slc32a1-Cre;Ai9 
line relative to the number of Vgat-Cre;Ai9+ neurons in the ZI. A bar graph on the right 
(red) showing the percentage Lhx6-immunostained neurons and TdTom expression from 




mice in each group.(d) A bar graph on the left (blue) shows the percentage Lhx6-
immunostained neurons and GAD1 expression from fISH relative to the fraction of 
GAD1+ neurons in the ZI. A bar graph on the right (red) shows the percentage Lhx6-
immunostained neurons and GAD1 expression from fISH over the number of Lhx6-
immunostained neurons in the ZI. N=3 mice in each group.(e-g) Co-localization of GFP 
in Lhx6-eGFP mice (green, e) with GAD1 mRNA expression from fISH (red, f) in the ZI. 
Merged image of e and f are shown in g. Arrows indicate a few examples of Lhx6 and 
Gad1 co-localization. Scale bar = 100 μm.  
 
 
Figure 2.3.2. Immunohistochemical analysis of Lhx6-expressing neurons with common 
cortical interneuron markers. (a-d) Representative images showing parvalbumin-
immunostained neurons (a, red) in the ZI and Lhx6-eGFP neurons (b, green) in the ZI. 
Merged image of a and b are shown in c. Magnified image of c is shown in d. a-c, Scale 
bar = 100 μm. d, scale bar = 25 μm. (e-h) Representative images showing somatostatin 
neurons from fISH (e, red) in the ZI and Lhx6-eGFP neurons (f, green) in the ZI. Merged 
image of e and f are shown in g. Magnified image of g is shown in m. e-g, Scale bar = 
100 μm. h, scale bar = 25 μm. (i-l) Representative images showing Vgat-Cre;Ai9 (i, red) 
and Lhx6-immunostained neurons (j, green) in the ZI. Merged image of i and j are shown 
in l. Magnified image of l is shown in l. i-k, Scale bar = 100 μm. l, scale bar = 25 μm 
 
Hypothalamic Lhx6-expressing neurons are GABAergic and can release GABA, 




in the ventral zona incerta, with Lhx6 represents 31% and 44% of all Gad1 and Slc32a1-
positive cells in this region, respectively (Figure 2.3.1 c,d).  
 
2.4 Hypothalamic Lhx6-expressing neurons are heterogeneous at the molecular level 
Using both RNA-seq data and fluorescence in situ hybridization (fISH), we have 
identified more molecular markers that are co-expressed with sub-populations of 
hypothalamic Lhx6-expressing neurons.  These include Dopamine Receptor D2 (Drd2), 
Proenkephalin (Penk), Calbindin, Neurexophilin1(Nxph1) (Figure 2.4.1) Tac1, and 





Figure 2.4.1. Immunohistochemical analysis of Lhx6-expressing neurons with some other 
molecular markers. (a) Dopamine Receptor D2 (Drd2), (b)Calbindin, (c) 
Neurexophilin1(Nxph1), (d)Proenkephalin(Penk), 
 
Thus, hypothalamic Lhx6-expressing neurons are highly heterogeneous, and may 
be multifunctional. For the functional studies which will be shown in the next chapter, we 
have focused on Lhx6-expressing neurons in the zona incerta (ZI). The ZI is adjacent to 
the lateral hypothalamus where two sleep/wake cycle population of neurons, hypocretin 
and melanin-concentrating hormone (MCH)-expressing cells are located. As a result, ZI 




show that ZI Lhx6-expressing neurons are not either hypocretin or MCH-expressing 
neurons (Figure 2.4.2). 
 
Figure 2.4.2. Immunohistochemical analysis of Lhx6-expressing neurons.(a-c) 
Representative images showing MCH-immunostained neurons (a, red) in the LH and 
Lhx6-eGFP (b, green) neurons in the ZI. Merged image of a and b are shown in c. Scale 
bar = 100 μm. (d-f) Representative images showing HCRT-immunostained neurons (d, 
red) in the LH and Lhx6-eGFP neurons (e, green) in the ZI. Merged image of d and e are 
shown in f. Scale bar = 100 μm. 
 
2.5 Receptors of wake-promoting neurotransmitters expressed in hypothalamic 
Lhx6-expressing neurons 
We have also used RNA-Seq on P8 Lhx6-EGFP offspring to determine that 
hypothalamic Lhx6-expressing neurons are highly enriched for both nicotinic and 




serotonin receptor subtypes (Figure 2.5.1, Figure 2.5.2), which indicates hypothalamic 
Lhx6-expressing neurons in the hypothalamus might receive input from wake-promoting 
neurons. Since Gi-coupled inhibitory receptors for wake-associated neurotransmitters are 
particularly prominent in Lhx6-positive neurons, it also suggests that hypothalamic Lhx6-
expressing neurons might be sleep-promoting.  Finally, since acetylcholine is known to 
act as both a wake-promoting and REM-promoting neurotransmitter[52], it is also 
possible that these neurons may be activated during REM sleep. 
 
Figure 2.5.1. Receptors for wake-promoting and REM-promoting neurotransmitters 
enriched in P8 hypothalamic Lhx6 neurons. The blue bar shows the gene expression 
levels in hypothalamic Lhx6-positive neurons. The red bar shows the gene expression 







Figure 2.5.2. (continue to Figure 2.5.1)Wake-promoting and REM-promoting Receptors 
enriched in P8 hypothalamic Lhx6 neurons. Blue bar showed the gene expression levels 
in hypothalamic Lhx6-positive neurons. Red bar showed the gene expression levels in 
hypothalamic Lhx6-negative neurons. 
 
In summary, hypothalamic Lhx6-expressing neurons are GABAergic interneurons, 
and co-express a considerable number of genes with cortical Lhx6-expressing neurons. 
We also show that hypothalamic Lhx6-expressing neurons show unique gene expression 
patterns which may confer different developmental characteristics and behavior function 





Chapter 3. Developmental characteristics of 
hypothalamic Lhx6 neurons 
   I showed previously in Chapter 1 how Lhx6, a transcription factor, is necessary 
for cortical interneuron precursors to migrate and differentiate. In this chapter, I aim to 
investigate whether the developmental role of Lhx6 in the hypothalamus would be similar 
or different to the cortex.  
3.1 Hypothalamic Lhx6-expressing neurons do not undergo tangential migration 
Lhx6-expressing interneuron precursors undergo long-distance tangential 
migration in the developing telencephalon to populate dorsal structures such as the cortex 
and hippocampus [31,32].  This raises the question as to whether a similar process would 
occur in the hypothalamus.  Previous studies have reported that hypothalamic neuronal 
precursors undergo tangential migration during development [107, 108].  Understanding 
the extent to which this occurs will improve our understanding of hypothalamic cell 
lineage, and defects in cell migration during development may underlie a wide range of 
genetic disorders of metabolism, mood and social interaction. We first fate mapped Lhx6-
expressing cells by crossing Lhx6-CreERT2  knock-in mouse with a Cre-dependent 
R26IAP reporter line (generously shared from the Nathans lab) in the hypothalamus and 
treated with tamoxifen at the gestational time points of E10, E12.5 and E14. The pups 
were taken down at P1 and P8 and Cre-dependent AP expression was observed. By 
carefully observing the distribution of tamoxifen-induced Lhx6 expression, we did not 




embryonic time points. We concluded that hypothalamic Lhx6-expressing neurons do not 
undergo a long distance dispersal, but rather migrated radially and differentiated close to 
their point of origin (Figure 3.1.1).  
 
 
Figure 3.1.1 Hypothalamic Lhx6 neurons of P1 pup brains do not migrate demonstrated 
by fate mapping of Lhx6 neurons by giving tamoxifen at E12.5.coronal sections showed 
different magnification pictures. The leftmost was under 2.5X, while the right four panels 
were under 10X and 20X showing the left and right side of the lateral hypothalamus. 
 
3.2 Lhx6 is required for the survival of hypothalamic Lhx6-expressing neurons 
As previously mentioned, Lhx6 labeled a specific group of neurons in the 
developing and adult zona incerta(ZI), dorsomedial hypothalamus (DMH) and posterior 
hypothalamus (PH). To first characterize the role of Lhx6 hypothalamic development, we 
used homozygote Lhx6-CreERT2 knock-in mice as functional nulls, which would not 




expression of Lhx6 mRNA in the hypothalamus.  However, Lhx6 mRNA expression (but 
not protein expression) in telencephalic structures such as the cortex, hippocampus and 
amygdala was still observed (Figure 3.2.1).  
 
Figure 3.2.1. Lhx6 expression in P18 homozygous Lhx6CreER mice. Lhx6 was not 
expressed in hypothalamus (Zona incerta) of homozygous Lhx6CreER mouse (a, b, c,d) 
by a two-color ISH analysis of Lhx6(blue) and TH(brown), but was retained in amygdale 
and cortical region (e, f, g, h) . TH, tyrosine hydroxylase. Lhx6 protein was completely 
absent in hypothalamus(i,j) and other brain regions(not shown) and abnormally high 
levels of c-fos staining were observed in Lhx6 mutant cortex (k, l). 
 
This led us to hypothesize that the Lhx6-expressing neurons in the hypothalamus 




animals.  In either case, this shows that Lhx6 plays a fundamentally different roles in the 
development of hypothalamic neurons compared to telencephalic interneurons.     To test 
whether Lhx6 is required for the survival of hypothalamic neurons, we crossed Lhx6-
CreER, Lhx6lox/lox mice and Ai9-Tdtomato to generate Lhx6-CreER/Lhx6lox;Ai9 mice.  
Loss of Lhx6 expression in this line by a tamoxifen-induced recombination should also 
activate Tdtomato expression. If Lhx6-expressing neurons in the hypothalamus require 
the Lhx6 gene for their survival, Lhx6-expressing neurons would die after the Cre 
activation, and Lhx6-negative, TdTomato-positive cells should not be observed. In 
contrast, if Lhx6-expressing neurons survive but just lose Lhx6 expressin, those neurons 
would express Tdtomato but not Lhx6. We used this Lhx6-CreER/Lhx6lox;Ai9 line to 
delete Lhx6 expression by gavage delivery of tamoxifen at E16 (chase to P0) and P10 
(chase to P16) (Figure 3.2.2) and compared these results to Lhx6-CreER, Lhx6+;Ai9 mice 
as the control group. By immunostaining using antibody against Lhx6 and Tdtomato, we 
generated green cells (only Lhx6+), red cells (only Tdtomato+) and yellow cells (both 
Lhx6+ and Tdtomato+). We found that there are fewer number of  red cells in mutant 
hypothalamus (Red cells/Red cells+Yellow cells ratio E16: 0.08, P10:0.14) than mutant 
telencephalic structures (cortex or amygdala) (Red cells/Red cells+Yellow cells ratio 
E16:0.58, P10:0.36),  which is in contrast to the control animals hypothalamus (Red 
cells/Red cells+Yellow cells ratio E16: 0.00, P10:0.001) and telencephalic structures 
(cortex or amygdala) (Red cells/Red cells+Yellow cells ratio E16:0.36, P10:0.038). These 
findings indicate that Lhx6 is required for the maintenance of Lhx6 neurons in the 






Figure 3.2.2 . Schematic procedure explain Lhx6 is required for the survival of Lhx6-
expressing neurons in hypothalamus, but not in telencephalic structures. (A) Schematic 
indicate the generation of mouse Lhx6CreER/lox:Ai9. (B) Lhx6CreER/lox:Ai9 mutant 
animal showed less red cells in zona incerta compared to Lhx6CreER/+:Ai9 control 
animal. (C) a reduction in the number of red hypothalamic neurons relative to yellow 
neurons when compared to Lhx6-expressing cells of the telencephalon( R/R+Y: ratio of 






Figure 3.2.3. Experimental demonstration that Lhx6 is required for hypothalamic Lhx6-
positive cells survival. (A) control staining (Lhx6CreER/+ -Td) compared to mutant 
staining (Lhx6CreER/Lox -Td); (B)controls and mutants statistics on R/R+Y (number of 
red cells divided by total of red and yellow cells) compared between hypothalamic and 
cortical Lhx6 cells tamoxifen injected at E16 or P10. 
 
In conclusion, in the absence of Lhx6, Lhx6-expressing neuronal precusors in 




However, Lhx6 is necessary for the survival of Lhx6-expressing neurons in the 
hypothalamus.  
 
3.3 Zona incerta Lhx6-expressing neurons send long-range projections to areas 
containing wake-active neurons. 
Although hypothalamic Lhx6-expressing neurons do not undergo tangential 
migrate, their axonal processes reach out to send long-range projections to the amygdala, 
midbrain and brainstem.  Here I show the local and long-range projections of 
hypothalamic Lhx6-expressing neurons. To first characterize postsynaptic projections of 
the Lhx6+ ZIv neurons, we injected AAV9-FLEX-ChR2-eYFP virus into the ZI of P60 
Lhx6-CreERT2 knock-in mice [84] (Fig. 3.3.1 a).  Following injection of 4-OHTx, we 
observed local projections both within the ZI and adjacent LH (Fig. 3.3.1 b-e).  The 
neuropil of YFP-positive transduced cells overlapped with the distribution of A13 
dopaminergic cells (Fig. 3.3.1 b,d).  Furthermore, projections were also associated with 





Figure 3.3.1 Lhx6-expressing neurons locally project to HCRT-expressing neurons in the 
lateral hypothalamus (a) Schematics of ChR2-eYFP virus construct and virus injection 
site in the ZI of Lhx6-Cre line. (b-e) Distribution of ChR2-eYFP injected Lhx6+ neurons 
(green) in the ZI (b, d) and neural projections of Lhx6+ neurons in the lateral 
hypothalamus (LH, k). TH immunostaining (red) was used to demarcate A13 
dopaminergic neurons in the ZI (b), and hypocretin (HCRT, red) was used to demarcate 
the LH (d). Magnified images of the ZI and LH are shown in c, e respectively. Note that 
Lhx6+ neurons in the ZI project around HCRT-expressing neurons in the LH (d). Scale 
bar = 100 μm. 
 
A limited number of selective long-distance projections were also observed.  A 
small ascending projection to the central nucleus of amygdala was seen (Fig. 3.3.2), 
along with much more extensive descending projections to monoaminergic midbrain and 
hindbrain populations.  These include pars compacta of the substantia nigra, the ventral 
tegmental area and the dorsal raphe nucleus (DR).  Substantial descending projections 
were also observed to the ventrolateral periaqueductal gray (vlPAG) (Figure 3.3.2).   
Essentially identical results were observed following transduction of Lhx6-Cre mice (Fig. 
3.3.2; data not shown).   These targets overlap substantially with previously reported 




to thalamus are observed .  Pvalb-expressing GABAergic ZI neurons, in contrast, project 
extensively to the thalamus, but not to LH or midbrain targets of Lhx6+ cells (Fig. 3.3.3 
i-p).  It seems clear that hypothalamic Lhx6-expressing neurons postsynaptically target 
wake-promoting cells in different brain regions, which provides us the direction for 
functional studies for hypothalamic Lhx6-expressing neurons, which have primarily  





Figure 3.3.2 Additional data showing mapping of neural projection sites of Lhx6-
expressing neurons in the ventral of Zona incerta.(a) Schematics showing neural 
projection sites of Lhx6+ neurons in the ZI across multiple brain regions after ChR2-
eYFP virus injection into the ZI of Lhx6-Cre line. Amyg = amygdala, CPu = caudate 
putamen, DR = dorsal raphe nucleus, ECIC = external cortex of the inferior colliculus, 
Hip = hippocampus, LH = lateral hypothalamus, MGP = medial globus pallidus, MM = 




paranigral nucleus, SNpc = substantia nigra. (b-k) Representative images of eYFP-
positive axonal processes of Lhx6-+ neurons of the ZIv (green) in amygdala (b), 
substantia nigra (d), periaqueductal gray (PAG) (f), ventral tegmental area (VTA) (h), 
and dorsal raphe nucleus (DR)(j). TH (red) immunostaining was used to demarcate 
amygdala, substantia nigra, PAG, and VTA in b, c, d, e, f, g, h, and i, and TPH (red) 
immunostaining was used to demarcate DR in j and k. Magnified images of b, d, f, h, and 





Figure 3.3.3 Projection sites of Slc32a1 and Pvalb-expressing cells in the ZI. 
(a, e, g) Low-powered images of Slc32a1-Cre mouse injected with flexed rAAV-
eGFP in ZI.   High-powered images demonstrate infection in ZI and LH (b), central 
thalamus (c, f), amygdala (d), and PAG (h).  White arrows indicate sparse GFP+ 




rAAV-eGFP in ZI.  GFP+ processes are detected in ZI (j) and central thalamus (k, n).  
No signal is detected in amygdala (l), while very little signal is seen in PAG (p).  Amyg = 
amygdala, DR = dorsal raphe nucleus, Hip = hippocampus, MM = mammillary nucleus, 
PAG = periaqueductal gray. All data was obtained from Allen Brain Atlas Mouse 
Connectome Project. Experiment number 17106613 for Scl32a1-IRES-Cre and 
301539438 for Pvalb-IRES-Cre. Scl32a1-IRES-Cre (section 73 (a-d), section 58 (e-f), 
section 44 (g-h)). Pvalb-IRES-Cre (section 68 (i-l), section 60 (m-n), section 45 (o-p)). 
 
 
In this chapter, we characterized the developmental functions of Lhx6 in 
thehypothalamus. Unlike Lhx6-expressing neurons in the cortex, hypothalamic Lhx6-
expressing neurons do not undergo long-range tangential and Lhx6 is essential for the 
survival. In addition, hypothalamic Lhx6-expressing neurons send both local and long-
range projections. These postsynaptic targets of Lhx6-expressing neurons in the 
hypothalamus provided us to hypothesize that hypothalamic Lhx6-expressing neurons 
might be involved with sleep/wake cycle regulation. The next chapter will test the 














Chapter 4. c-Fos functional screening for hypothalamic 
Lhx6-expressing neurons 
As described in Chapter 1, most studies of hypothalamic neurons focus on their 
role in regulating innate behaviors.  In the previous chapter, we looked at the markers, 
locations and postsynaptic targets of  hypothalamic Lhx6-expressing neurons, and we 
found some clues which directed us to hypothesize hypothalamic Lhx6-expressing 
neurons might be involved with sleep/wake regulation. To characterize this further, we 
first applied immunohistochemical staining for c-Fos, an immediate early gene that is a 
faithful marker of neuronal activation, to determine what behavioral states activated 
hypothalamic Lhx6 neurons.  In addition to sleep/wake behavior testing, we ran many 
other behavior paradigms.  We observed robust and selective differences in Lhx6 
neuronal activity in during periods of elevated sleep pressure in the zona incerta, and not 
in other hypothalamic Lhx6-expressing neurons.  
 
4.1 Many different behavior paradigms do not selectively activate Lhx6-expressing 
neurons in hypothalamus 
To screen out the potential behavior functions for hypothalamic Lhx6-expressing 
neurons, we conducted various behavior paradigms and c-fos staining.  Since Lhx6-
expressing neurons are located in the zona incerta, which plays an important role in 
somatosensory processing, we tested whether whisker stimulation might activate ZI 




play a role in thermoregulation, we placed mice into cold room for 30 mins and checked 
c-fos staining. We also also fasted mice for 24 hours as to check their hunger behavior. 
We placed bobcat urine into animal cages to induce innate fear response, which is also 
modulated by neurons in the posterior hypothalamus, which resulted in immediate 
cessation of movement upon sensing the bobcat urine smell. However, none of the 
behavior paradigms resulted in selective activation of c-Fos expression in hypothalamic 
Lhx6-expressing neurons.  
 
4.2 Zona incerta (ZI) Lhx6-expressing neurons are highly activated with high sleep 
pressure at Zeitgeiber Time 0 (ZT0) 
Both sleep probability and sleep pressure are highest at the start of the light phase 
in nocturnal animals such as mice [94]. If hypothalamic Lhx6-expressing neurons are 
sleep-promoting, we would predict they will be most active at the time of highest sleep 
(lights on). We tested this by assessing immunohistochemical colocalization of c-fos and 
eGFP staining in the ZI of Lhx6-eGFP mice that were maintained on 14:10 hr light:dark 
cycle, we identified that c-fos expression was elevated in Lhx6+ ZI neurons at ZT0 
(lights on) relative to ZT14 (lights off) (Figure.4.2.1a-e). Based on these results, it 
appears that ZI Lhx6-expressing neurons are most active at times of high sleep pressure. 





Figure 4.2.1 The activity of Lhx6-expressing neurons in the ZI is activated by sleep 
pressure. Representative images of cFOS immunostaining (red) and Lhx6-eGFP 
expression (green) in the ZI across Zeitgeber time (ZT) – ZT0 (a), ZT6 (b), ZT14 (c), 
ZT18 (d), Scale bar = 100 μm. Bar graphs show the percentage of cFOS+ Lhx6+ 
neurons in the ZI across ZT (e) *= P < 0.05, ** = P < 0.01, linear mixed-effect model fit 
by REML; P=0.0367 (e), Two tailed one-way ANOVA.  N=4 mice in each group, 4 brain 
sections were analyzed bilaterally for each mouse. 
 
 
4.3 Zona incerta Lhx6-expressing neurons are sensitive to sleep pressure when sleep 




Since ZI Lhx6-expressing neurons are most activate during the time of day with 
highest sleep pressure, we tested whether induction of artificial sleep pressure through 
sleep deprivation could also activate ZI Lhx6-expressing neurons. To sleep deprive the 
mice, we kept the mice awake by touching the animals gently with a small brush and 
stimultted them with novel toys. This procedure lasted for 6 hours from ZT0 (7am) to 
ZT6(1pm).  We also performed an analysis of sleep deprivation combined with recovery, 
in which the mice were allowed to sleep for one hour after the same 6 hours sleep 
deprivation. We observed that both sleep deprivation and sleep deprivation combined 
with recovery sleep significantly increased c-fos expression in Lhx6+ ZIv neurons (Fig. 
2k-m), demonstrating that these neurons were activated by both sleep itself and high 
sleep pressure.  These data further highlight that Lhx6-expressing neurons in the ZI could 





Figure 4.3.1 The activity of Lhx6-expressing neurons in the ZI is activated by sleep 
deprivation and recovery. Representative images of cFOS immunostaining (red) and 
Lhx6-eGFP expression (green) in the sleep-deprived (a) and sleep-deprived with 
recovery sleep (b), Scale bar = 100 μm. Bar graphs show the percentage of cFOS+ 
Lhx6+ neurons in the ZI across ZT (c) *= P < 0.05, ** = P < 0.01, linear mixed-effect 
model fit by REML; P=0.0383 (c), Two tailed one-way ANOVA.  N=4 mice in each group, 
4 brain sections were analyzed bilaterally for each mouse. 
 
 
In summary, to study the potential function of hypothalamic Lhx6-expressing 
neurons, we first applied c-fos staining to identify which specific behavior paradigm can 
activate the cells. We found out ZI Lhx6-expressing neurons were highly activated by 
sleep pressure, and that ZI Lhx6-expressing neurons are potentially sleep-promoting. To 
direct demonstrate this, I will describe genetic and chemogenetic  experiments in the next 
chapter which demonstrate that ZI Lhx6 neurons are both necessary and sufficient to 















Chapter 5. Sufficiency and necessity of zona incerta 
Lhx6-positive neurons' role in sleep/wake regulation 
These studies have begun to shed light on the physiological functions of 
hypothalamic Lhx6-expressing neurons, in particular neurons located in the zona incerta 
(ZI). From our c-fos staining experiments, we knew that sleep pressure can activate ZI 
Lhx6-expressing neurons. To prove that ZI Lhx6-expressing neurons are involved in 
sleep/wake regulation, we have conducted both intersectional genetic and chemogentic  
experiments to demonstrate that ZI Lhx6 neurons are both necessary and sufficient to 
promote sleep. 
 
5.1 Conditional knockout of Lhx6 in hypothalamus results in sleep reduction 
We observed that straight Lhx6 knock-out mice die at 3 weeks postnatal due to 
failure to wean properly, as previously described, and are not suitable for studying sleep 
physiology.  However, intersectional Cre/lox studies can induce selective deletion of 
Lhx6 in the developing hypothalamus, which may be suitable for these studies. Since 
deletion of hypothalamic Lhx6 appears to lead to death of these cells, this allows a 
powerful and effective methods of determining whether hypothalamic Lhx6-expressing 
neuronal death can affect sleep behavior. To fulfill this, we have used Foxd1-Cre knock-
in mice,  as Foxd1 shows selective and widespread activity in prethalamic and 
hypothalamic and neuronal progenitors within the CNS (Figure 5.1.2 a)[95].  We used 




of Lhx6 throughout the hypothalamus and ZI, relative to Foxd1-Cre;Lhx6lox/+ controls as 
determined by immunostaining, while Lhx6 expression in telencephalic structures such as 
cortex and amygdala was preserved (Figure 5.1.1).   
 
Figure 5.1.1. Lhx6 expression was selectively deleted in the diencephalon but kept in the 
telencephalon of Lhx6 conditional knockout Foxd1-Cre;Lhx6lox/lox (CKO) line. 
Representative images of Lhx6-immunostaining (green) in the cortex (a-d), 
amygdala (e-h), and ZI (i-l) of control (a, b, e, f, i, j) and CKO (c, d, g, h, k, l) groups. 
Magnified images of a, c, e, g, i, and k are shown in b, d, f, h, j, and l respectively. Note 
that an absence of Lhx6 expression in the ZI of CKO group. Scale bar = 100 μm. 
 
Foxd1-Cre;Lhx6lox/lox mice were viable, and no obvious developmental, 
anatomical, or behavioral defects were observed (Figure 5.1.2).  These mice were then 




elevated plus-maze, grip strength and rotarod, and no differences were observed relative 
to Foxd1-Cre;Lhx6lox/+ controls.   Analysis of wheel running behavior also revealed that 
circadian activity rhythms were normal (example showed in Figure 5.1.3).  
 
Figure 5.1.2 Lhx6 CKO mice do not display obvious behavioral abnormalities other than 
changes in sleep patterns.Light-dark preference test (a), elevated plus maze (b & c), grip 
strength (d), open field test (e), and rotarod (f) were conducted in control (red) and CKO 
(blue) groups, including analyzing dark. No significant difference, P>0.1 for all behavior 







Figure 5.1.3 An example of wheel running behavior on Lhx6 conditional knockout mice 
with normal circadian rhythm.  
 
To test sleep behavior, we implanted a EEG/EMG chip on the mouse skull for 
recordings (Figure 5.1.4).  A tethered wire was connected to the chip for transferring the 
EEG/EMG signal to a preamplifier, which upload the data into a computer (Figure 5.1.5). 
The EEG/EMG traces and hands-on data sleep stages analysis was shown in Figure 5.1.6. 





Figure 5.1.4 EEG/EMG implantation surgery on mouse (left) and wire tethered 
connected to a preamplifier (right).  
 







Figure 5.1.6 EEG/EMG example traces and data analysis. (a) control example, the upper 
colorful line was hands-on labeling for sleep stages, WAKE(yellow), REM(red) and non-
REM(purple); 2nd line, spectrum of EEG signal; 3rd line, raw EEG signal; bottom line, 
raw EMG signal (b) Lhx6 conditional knockout example.  
 
A blinded analysis of EEG and EMG data obtained from adult male Foxd1-
Cre;Lhx6lox/lox mice revealed a highly significant increase in the fraction of time spent 




Spectral analysis of Foxd1-Cre;Lhx6lox/lox mice revealed a strong reduction in the delta 
wave band, confirming the disruption of NREM sleep in these animals.  However, the 
relative decrease in the fraction of REM sleep in mutant mice was even more dramatic 
than that of NREM.  These data demonstrate that disrupting the differentiation of 
hypothalamic Lhx6-expressing neurons results in strong and selective decreases in sleep 
time. 
 
Figure 5.1.7 Selective loss of Lhx6 expression in the diencephalon reduces both NREM 
and REM sleep(a) Schematics showing generation of the diencephalic-specific Lhx6 
conditional knockout (CKO) line by crossing Foxd1-Cre and Lhx6lox/lox lines.(b) EEG 
analysis showing the percentage of day-night cycle - wake, NREM sleep, and REM sleep 
- in control (Foxd1-Cre;Lhx6lox/+) and CKO groups. * = P < 0.05, ** = P < 0.01, two-




graph showing fast Fourier transform (FFT) analysis of EEG power spectrum frequency 
of NREM stage of CKO line (blue) compared to the baseline (control, red)(c), with a bar 
graph showing collapsed EEG frequency data of spectrum band between control (red) 
and CKO group (blue)(d). * P < 0.05, two-tailed paired t-test, Wilcoxon-Mann-Whitney 
test.  N = 8 control and 8 CKO mice. 
 
The conditional knockout of Lhx6 in the hypothalamus led to disruption in both 
REM and non-REM sleep, which demonstrated that hypothalamic Lhx6-expressing 
neurons are necessary to promote sleep. However, to sufficiently provide evidences to 
support that ZI Lhx6-expressing neurons can directly regulate sleep, we needed to 
directly manipulate the activity of ZI Lhx6-expressing neurons and observe sleep/wake 
activity.  
 
5.2 Chemogenetic activation of zona incerta (ZI) Lhx6-expressing neurons promotes 
both REM and non-REM sleep 
We applied DREADD-based chemogenetic analysis [96] to selectively activate 
and silence Lhx6+ ZI neurons to directly test whether Lhx6+ ZIv neurons were necessary 
and sufficient for induction of sleep.  We first had to rule out any non-DREADD-based 
effect on sleep of clozapine N-oxide (CNO), the ligand used to activate DREADD 
constructs.  When CNO was delivered to mice previously by bilateral stereotaxic 
injections of AAV9-FLEX-mCherry to the ZI, we observed no differences in EEG/EMG 





Figure 5.2.1 CNO does not affect sleep in Lhx6-Cre mice injected with AAV-mCherry in 
the ZI. (a) EEG analysis showing the percentage of day-night cycle with wake (top), 
NREM sleep (middle), and REM sleep (bottom) across ZT with saline- or CNO-injection 
in AAV9-mCherry group.  (b) Graphs of EEG analysis showing amount of time spent 
across ZT in wake (top), NREM sleep (middle), and REM sleep (bottom) after injection of 




This finding is in line with previous studies that have used DREADD-based 
approaches to study sleep [97, 98, 99].  We next conducted bilateral stereotaxic injections 
of AAV9 encoding the Cre-dependent hMD3q Gq-coupled activating DREADD to the ZI 
of Lhx6-Cre mice (Figure 5.2.2 a,b; Figure 5.2.3).  After intraperitoneal injection of CNO, 
by c-Fos staining we observed robust induction of c-fos activity in transduced cells 
relative to vehicle after 1hr of injection, which can confirm successful DREADD 
activation of Lhx6+ neurons (Figure 5.2.4) by the Gq DREADDs. As a result, this 
DREADDs chemogenetic tools could allow us to test whether Lhx6+ ZIv neuron 
activation was sufficient to induce sleep by activation of ZI Lhx6 neurons. At all times 
tested except ZT23, when sleep pressure is highest, we observed a significant increase in 
time spent in REM during the 12 hrs after CNO injection.  Meanwhile, significant 
decreases in wake time and increases in NREM sleep were observed following CNO 
administration at ZT5 and ZT11, with a strong increase in the delta band during NREM 
sleep (Figure 5.2.2 c,d; Figure 5.2.3 ).  These effects were strongest between 2 and 8 hrs 
following CNO administration, and returned to baseline by 12hrs post-injection. A 
substantial increase in the delta band was observed during NREM sleep after CNO 
delivered at ZT5, between 2 to 4 hrs post-injection. Selective transduction of Lhx6+ ZI 
neurons was confirmed by postmortem examination of all tested animals in DREADDs 





Figure 5.2.2 DREADD-dependent activation or inhibition of Lhx6-expressing neurons in 
the ZI can induce or inhibit NREM and REM sleep(a) Schematics showing sleeping 
recording paradigm (EEG and EMG recording) with saline- or CNO-injection in hM3Dq 
(B-D) or hM4Di (E-G) groups.  Each individual mouse is assayed under the conditions 




into the ZI of Lhx6-Cre line.(c) EEG analysis showing the percentage of time spent 
during the 12 hour post-injection interval in wake (top), NREM sleep (middle), and REM 
sleep (bottom) - across ZT with saline- or CNO-injection in hM3Dq groups. * =P < 0.05, 
** = P < 0.01, two-tailed paired t-test, Wilcoxon-Mann-Whitney test.  N = 8 mice. (d) 
Graphs of EEG analysis showing amount of time in wake (top), NREM sleep (middle), 
and REM sleep (bottom) after injection of saline- or CNO-injection at ZT5 in hM3Dq 
groups. * = P < 0.05, ** = P < 0.01, two-tailed paired t-test, Wilcoxon-Mann-Whitney 
test.  N = 8 mice. (e) Schematics showing hM4Di-mCherry virus construct and injection 
of virus into the ZI of Lhx6-Cre line.(f) EEG analysis showing the percentage of 12-hour 
interval cycle with wake (top), NREM sleep (middle), and REM sleep (bottom) with 
saline- or CNO-injection in hM4Di groups. * < 0.05, ** = P < 0.01, *** = P <0.001, 
two-tailed paired t-test, Wilcoxon-Mann-Whitney test.  N = 8 mice.(g) Graphs of EEG 
analysis showing amount of time spent during the 12 hour post-injection interval in wake 
(top), NREM sleep (middle), and REM sleep (bottom) after injection of saline- or CNO-
injection at ZT5 in hM4Di groups. * = P < 0.05, ** = P < 0.01, two-tailed paired t-test, 





Figure 5.2.3 Additional data from Gq DREADD-injected Lhx6-Cre mice (continuation 
from Figure 5.2.2).(a) Schematics showing the construct of AAV-hM3Dq virus and the 
injection site of virus into the ZI of Lhx6-Cre line. (b) Graphs of EEG analysis showing 
amount of time spent across ZT in wake (top), NREM sleep (middle), and REM sleep 
(bottom) after injection of saline- or CNO-injection at ZT17 in hM3Dq groups. * = P < 
0.05, ** = P < 0.01, two-tailed paired t-test, Wilcoxon-Mann- Whitney test.  N = 8 mice.   
(c-d) A graph showing fast Fourier transform (FFT) analysis of EEG power 
spectrum frequency of NREM stage of CNO-injected AAV-hM3Dq-infected mice (blue) 
compared to the baseline (saline-injection, red)(c), with a bar graph showing grouped 




injected (blue) hM3Dq groups (d). * = P < 0.05, two-tailed paired t-test, Wilcoxon-
Mann-Whitney test.  N = 8 mice.  
 
Figure 5.2.4 CNO activates c-fos expression in AAV-hM3Dq-injected Lhx6-Cre mice. 
(a-c) Representative images showing hM3Dq-mCherry expression (red) and cFOS 
immunostaining in the ZI of Lhx6-Cre line after saline (a) or CNO (b) injection. 
Magnified image of b is shown in c. Scale bar = 100 μm. (d) A bar graph showing the 
percentage cFos-immunostained neurons in hM3Dq-mCherry+ Lhx6-expressing neurons 
in the ZI. N = 4 mice/saline, N = 5/mice/CNO. *** = P < 0.001 (e-g) Representative 
images showing hM4Di-mCherry expression (red) and cFOS immunostaining in the ZI of 
Lhx6-Cre line after saline (D) or CNO (E) injection. Magnified image of B is shown in F. 
Scale bar = 100 μm. (h) A bar graph showing the percentage cFos-immunostained 
neurons in hM4Di-mCherry+ Lhx6-expressing neurons in the ZI. N = 3 mice/saline, N = 









Figure 5.2.5 AAV-DREADD infection site in Lhx6-Cre mice.(a) Schematics showing the 
distribution of AAV-DREADD infection (red) across the full rostrocaudal extent of the ZI 
after AAV-DREADD was injected into the ZI of Lhx6-Cre line.(b-d) Representative 
images showing co-expression of hM3Dq DREADD infection in the ZI of Lhx6-Cre line 
(b, red) with Lhx6 immunostaining (c, green), and merged image of b and c is shown in d. 
Magnified image of d is shown in d1. Scale bar = 100 μm.(e-g) Representative images 
showing co-expression of AAV-hM4Di infection in the ZI of Lhx6-Cre line (e, red) with 
Lhx6 immunostaining (f, green), and merged image of e and f is shown in g. Magnified 
image of g is shown in g1.  Scale bar = 100 μm. 
 
5.3 Chemogenetic silencing of Zona incerta Lhx6-expressing neurons reduces both 




After testing the effect by activation of ZI Lhx6-expressing neurons, we then 
examined the effect of silencing ZI Lhx6 neurons which can tell us whether Lhx6+ ZI 
neurons are necessary for sleep, after introducing the inhibitory Gi-coupled hM4Di 
DREADD to Lhx6+ ZIv neurons by bilateral stereotaxic injection (Figure 5.2.2 a,e; 





Figure 5.3.1 Additional data from AAV-hM4Di-injected Lhx6-Cre mice (continuation 
from Figure 5.2.2).(a) Schematics showing the construct of AAV-hM4Di virus and the 
injection site of virus into the ZI of Lhx6-Cre line. (d) Graphs of EEG analysis showing 
amount of time spent across ZT in wake (top), NREM sleep (middle), and REM sleep 
(bottom) after injection of saline- or CNO-injection at ZT17 in hM4Di groups. * = P < 
0.05, ** = P < 0.01, two-tailed paired t-test, Wilcoxon-Mann-Whitney test.  N = 8 mice.  
(c-d) A graph showing fast Fourier transform (FFT) analysis of EEG power spectrum 
frequency of NREM stage of CNO-injected AAV-hM4Di (blue) compared to the baseline 
(saline-injection, red)(c), with a bar graph showing grouped EEG frequency data of 
spectrum band analysis between saline- (red) and CNO-injected (blue) hM4Di groups (d). 
* = P < 0.05, two-tailed paired t-test, Wilcoxon-Mann-Whitney test.  N = 8 mice.   
 
Using a similar stimulation paradigm to that used for the activating DREADD, we 
observed a complementary sleep phenotype (Figure 5.2.2 f,g; Figure 5.3.1).  Consistent 
with the Lhx6 conditional knockout results, CNO administration at ZT5 and ZT11 
significantly reduced time spent in REM.  A significant decrease in time spent in NREM, 
and corresponding increase in time spent awake, were also observed following CNO 
administration at ZT5 (Figure 5.2.2 f), with a strong decrease in the delta band during 
NREM sleep (Figure 5.3.1).   CNO administered in the middle of the light phase at ZT5 
resulted in a potent inhibition of both NREM and REM, and a corresponding increase in 
wake time, between 2 and 8 hours following injection (Figure 5.2.2 g).  No significant 
change was seen in total time spent in wake, NREM or REM in the 12 hours following 
injection, when CNO was administered either in the middle or the end of the dark phase 
at ZT17 and ZT23 (Figure 5.3.1).  However, when data were examined in two-hour 
intervals, decreases in NREM and REM and a corresponding increase in wake were 
observed only 8-10 hours following CNO administration, during the beginning of the 
light phase (Figure 5.3.1).  This suggests that the sleep-promoting effects of Lhx6+ ZIv 




immunostaining data demonstrating that these neurons are predominantly active during 
the light phase (Figure 4.2.1). 
From Gq and Gi DREADDs chemogenetic experiments, we have demonstrated 
that ZI Lhx6 neurons are sleep-promoting.  However, the mechanism by which this 
occurs is unclear, and is addressed in the next chapter.  
 
5.4 Zona incerta Lhx6 neurons promote sleep by locally inhibiting hypocretin (Hcrt) 
neurons in the lateral hypothalamus (LH) through GABA  
In Chapters 1~3, we observed that ZI Lhx6-expressing neurons are GABAergic 
interneurons, which can exert inhibitory action on other neuronal populations. As 
previously described, Hcrt neurons in the LH are adjacent to ZI Lhx6-expressing neurons. 
It is reasonable to hypothesize that ZI Lhx6-expressing neurons promote sleep by locally 
inhibiting Hcrt neurons. To demonstrate whether Lhx6+ neurons of the ZI directly inhibit 
Hcrt neurons, we applied optogenetics in combination with slice recordings. We 
generated Lhx6-Cre;Hcrt-eGFP mice, and selectively transduced ZI Lhx6-expressing 
neurons with AAV9 expressing FLEX-ChR2-mCherry (Figure 5.4.1 a). Using in slice 
electrophysiological recordings, we observed that transduced mCherry+ ZI Lhx6 neurons 
were efficiently activated by light pulses (Figure 5.4.1 b), and that LH Hcrt-eGFP 
neurons rapidly spiked in response to step current injection, making sure the slice 
optogenetics tool working on testing the inhibition from Lhx6 neurons to Hcrt neurons  
(Figure 5.4.1 c).  In all of the LH Hcrt-eGFP neuron from which we recorded, we 




inhibitory inward currents (Figure 5.4.1 d). The reason why we did see a depolarization-
like inhibitory waveform is because the we kept a high concentration of Cl- inside the 
recording glass pipette. This inhibition was with an average latency of 1.5 ms, indicating 
probable direct inhibitory projections from the Lhx6 ZI neurons to the Hcrt LH neurons.  
However, all the inhibitory effects were not removed by application of ionotrophic 
glutamate receptor antagonists CPP and NBQX, but were completely blocked by the 
GABAA receptor antagonist SR95531 (Gabazine), but not by NBQX and CPP.  Washout 
of SR95531 partially restored light-activated inhibitory inward currents (Figure 5.4.1 d-e). 
These experiments demonstrated that ZI Lhx6 neurons can inhibit hypocretin neurons via 
GABA directly.  
 
Figure 5.4.1 GABAergic Lhx6-expressing neurons in the ZI inhibit activity of HCRT-
expressing neurons in the LH, and the activity of Lhx6-expressing neurons in the ZI is 
activated by sleep pressure.(a) Schematics showing injection of ChR2-mCherry virus into 
the ZI of Lhx6-Cre;HCRT-eGFP line, and a red box showing HCRT-expressing neurons 
(green) in the LH and ventromedial portion of the ZI with Lhx6+ neurons (red). Scale 
bar = 100 μm.(b) Representative images of a membrane potential (left), and current 
responses (right) of ChR2-mCherry-expressing, Lhx6+ neuron to blue light 




current clamp mode (left) and 1s-long photostimulation results in continuous inward 
current in a voltage clamp mode (right).(c) Representative images of action potentials of 
Hcrt neurons in response to a step current injection (right).(d) Representative traces of 
membrane potential responses of a Hcrt neuron to photostimulation under glutamate 
receptor blockers (CPP/NBQX), with and without GABAAR blocker (SR95531). Note that 
high concentration of chloride in the internal solution evoked depolarizing responses in 
response to inhibitory input. (e) A summary graph of amplitudes of the first responses to 
photostimulation. 16 of 20 Hcrt neurons showed detectable responses to photostimulation. 
10 of the 16 responding neurons were tested with GABAAR blocker (SR95531), and the 
responses were abolished. 8 of the 10 cells were able to be used for SR95531 washout 
experiment. These 8 cells were plotted in the summary graph. Paired two-tailed t-test was 
used to test statistical significance between different conditions (n=8 cells from 4 mice; 
CPP/NBQX, 3.59 ± 0.99 mV vs CPP/NBQX/SR -0.03 mV ± 0.04 mV, p=0.0051, Shapiro-
Wilk Normality Test, paired t-test; CPP/NBQX/SR vs CPP/NBQX (SR washing out) 1.39 
± 0.46 mV, p=0.0194,Shapiro-Wilk Normality Test, paired t-test). 
 
These slice electrophysiology experiments suggested that ZI Lhx6-expressing 
neurons promote sleep by direct inhibition of Hcrt+ neurons in the LH.  To verify this 
finding in vivo, we performed a chemical epistasis experiment, and investigated whether 
there was a detectable interaction between the effects of inhibiting the activity of both ZI 
Lhx6-expressing neurons and blocking Hcrt signaling.  To do this Gi DREADD-injected 
mice were treated with both suvorexant [100], a hypocretin receptor antagonist, and CNO.  
These experiments demonstrated that suvorexant treatment could indeed reverse the 
effects of CNO (Figure 5.4.2), However, these data unable to determine whether the 
effects of CNO and suvorexant were addititve or non-additive, and could not definitively 
show that inhibition of Hcrt+ neurons is the only means by which Lhx6-expressing ZI 





Figure 5.4.2 Suvorexant effect on promoting sleep was canceled by DREADD-dependent 
inhibition of Lhx6-expressing neurons in the ZI (a) Schematics showing sleeping 
recording paradigm (EEG and EMG recording) with saline-, CNO, suvorexant or both-
injection in hM4Di mice.  Each individual mouse is assayed under the conditions 
indicated.(b) Schematics showing hM3Dq-mCherry virus construct and injection of virus 
into the ZI of Lhx6-Cre line.(c) EEG analysis showing the percentage of time spent 
during the 12 hour post-injection interval in wake (top), NREM sleep (middle), and REM 
sleep (bottom) - across ZT with saline- or CNO-injection in hM3Dq groups. * =P < 0.05, 
** = P < 0.01, two-tailed paired t-test, Wilcoxon-Mann-Whitney test.  N = 8 mice. (d) 
Graphs of EEG analysis showing amount of time in wake (top), NREM sleep (middle), 
and REM sleep (bottom) after injection of saline- or CNO-injection at ZT5 in hM3Dq 
groups. * = P < 0.05, ** = P < 0.01, two-tailed paired t-test, Wilcoxon-Mann-Whitney 
test.  N = 8 mice. (e) Schematics showing hM4Di-mCherry virus construct and injection 
of virus into the ZI of Lhx6-Cre line.(f) EEG analysis showing the percentage of 12-hour 
interval cycle with wake (top), NREM sleep (middle), and REM sleep (bottom) with 
saline- or CNO-injection in hM4Di groups. * < 0.05, ** = P < 0.01, *** = P <0.001, 
two-tailed paired t-test, Wilcoxon-Mann-Whitney test.  N = 8 mice.(g) Graphs of EEG 




(top), NREM sleep (middle), and REM sleep (bottom) after injection of saline- or CNO-
injection at ZT5 in hM4Di groups. * = P < 0.05, ** = P < 0.01, two-tailed paired t-test, 





























Chapter 6 Discussion and future work 
6.1 Discussion 
My thesis has focused on the study of a previously uncharacterized population of 
hypothalamic neurons labeled by a LIM homeodomain transcriptional factor Lhx6. Since 
the role of Lh6 in migration and differentiation of cortical interneurons has been 
extensively characterized, we started to investigate the developmental properties of Lhx6 
in hypothalamus.   We found substantial differences in gene expression patterns of 
hypothalamic and cortical Lhx6 neurons by RNA-Seq analysis. Lhx6 is essential for the 
development and migration of a large fraction of telencephalic interneurons [22].  In the 
diencephalon, however, Lhx6 is expressed in a much more restricted subset of 
GABAergic neurons that are not widely dispersed [76], and do not express canonical 
markers of telencephalic Lhx6+ interneurons, such as Pvalb and Som.  Lhx6 neurons in 
hypothalamus do not migrate, and most importantly, Lhx6 is required for the survival of 
hypothalamic Lhx6 neurons, in contrast to the cortical Lhx6 is not required.  The highly 
diverse functions of telencephalic interneurons, in contrast to the more specialized 
diencephalic Lhx6+ cells, are likely mediated by major differences in the organization of 
Lhx6-dependent transcriptional regulatory networks in both brain regions.  Further 
characterization of the genes that guide the development and function of diencephalic 
Lhx6+ neurons will provide further insight into molecular pathways that can potentially 





In our studies of the behavioral functions of hypothalamic Lhx6 neurons, we 
ultimately identified these cells as playing a central role in the promotion of sleep.   We 
can say this is a previously unidentified subpopulation of GABAergic neurons in the 
ventral zona incerta (ZIv) that are distinct from previously characterized subtypes of 
sleep-promoting neurons.  While the ZI has not previously been directly implicated in 
control of sleep, it is known to modulate cortical activity and behavioral arousal through 
direct inhibitory projections to both thalamus and cortex [76, 78]. Pvalb-expressing 
GABAergic neurons, the majority of neurons in the ZIv, directly inhibit sensory input to 
the posteromedial thalamic nucleus, and have been hypothesized to inhibit 
thalamocortical signaling during NREM sleep [101]. In this study, we identify 
GABAergic Lhx6+ ZIv neurons as a novel neuronal subtype that send descending 
projections to regions that contain wake-promoting neurons.  Most notably, these neurons 
are immediately presynaptic to the wake-promoting Hcrt+ neurons of the LH, and 
robustly inhibit their activity.  GABAergic ZIv neurons are interconnected, and receive 
input from wake-active neuronal populations [101, 102].  This raises the possibility that 
Pvalb+ and Lhx6+ ZIv neurons may coordinate their activity during wake and NREM, to 
separately regulate thalamocortical activity and suppress wake-active hypothalamic and 
midbrain neurons, respectively.   Furthermore, since complete ablation of the ZI does not 
induce changes in sleep/wake cycles, these findings imply that other as yet unidentified 
wake-promoting neuronal subpopulations may exist in this structure. 
 




Our findings demonstrate that Lhx6-expressing neurons in the hypothalamus, are 
GABAergic and distributed across the rostral-caudal gradient of the ZI, DMH and the PH. 
It is also important to note that experiments so far highlight that hypothalamic Lhx6-
expressing neurons are different in both function and gene expression profile compared to 
cortical Lhx6-expressing neurons, as hypothalamic Lhx6-neurons do not show classical 
markers that define Lhx6-expressing GABAergic interneurons in the cortex.  Importantly, 
fISH experiments highlight that there are multiple distinct subtypes of hypothalamic 
Lhx6-expressing neurons, even within a single structure such as the ZI, highlighting that 
Lhx6-expressing neurons are hypothalamus may be more heterogenous than the cortical 
Lhx6-expressing neurons. 
To address this, it will ultimately be necessary to profile the diversity of 
hypothalamic Lhx6-expressing neurons using single-cell RNA-Sequencing (SC-RNA-
Seq). Large-scale SC-RNASeq analysis makes it possible to profile diverse neuronal 
populations such as Lhx6-expressing neurons in the hypothalamus. However, given that 
hypothalamic Lhx6-expressing neurons only are a fraction of total number of cells in the 
hypothalamus, it is first important to enrich Lhx6-expressing neurons. Our Lhx6-eGFP 
line, which faithfully capture Lhx6-expression in the hypothalamus, will be highly useful 
as we can purify Lhx6-expressing neurons using FACS by enriching GFP-positive 
populations as previously done in bulk RNA-Seq. Although there are multiple methods of 
performing SC-RNASeq, our lab recently had success with using the Chromium Single 
Cell Solution Device (10x genomics) in the retina, and we anticipate that we will be able 
to apply this same method on FACS-isolated hypothalamic Lhx6-expressing neurons. 




neurons based on its transcript expression and using specific markers [40] to identify 
different functional subtypes of Lhx6-expressing neurons into the ZI, DMH and PH.  SC-
RNASeq will not only allow us to characterize heterogeneity of Lhx6-expressing neurons 
but will also help us to identify molecular cues that give rises to Lhx6 neuronal diversity. 
With more specific markers, we can identify the potential markers which act downstream 
of Lhx6 in hypothalamus to control cell survival.  
The presynaptic afferent to hypothalamic Lhx6 neurons are unknown. Since 
melanin-hormone concentrating (MCH) neurons have been reported to receive 
presynaptic innervation from vlPAG [103], we plan to conduct Callaway monosynaptic 
tracing [104] of hypothalamic Lhx6 neurons by stererotaxically injecting helper AAV 
genes and rabies virus into Lhx6-Cre mice. We expected to see that wake-promoting 
monoaminergic neurons in midbrain and brainstem send projections to hypothalamic 
Lhx6 neurons (HLINs), which is consistent with the mutual inhibitive "flip-flop" theory 
for sleep/wake circuitry.  
Since we have been able to demonstrate that HLINs are necessary for initiation 
and/or maintenance of REM sleep, we will next determine if these effects are mediated 
by descending inhibitory projections to the midbrain nucleic such as the vlPAG and DR 
nucleus. To do this, we will take advantage of a recently developed inhibitory DREADD 
variant that is selectively targeted to axonal processes and synaptic terminals [105]. We 
will selectively induce expression of this inhibitory DREADD in HLINs using bilateral 
stereotactic injections of AAV9-CMV-flex-hM4Di-neurexin-HA [105].  In addition to 
EEG recording devices, we will also implant a cannula directly immediately dorsal to the 




vlPAG and DR.   Following initial infection, we will then deliver either CNO or saline 
through the cannula during the middle of the light phase, and determine whether CNO 
infusion leads to a disruption of REM sleep that is comparable to that observed with 
conventional inhibitory DREADDs. To demonstrate the specificity of these effects, we 
will determine if they can be reversed by simultaneous infusion of bicuculline as 
described [106], which will trigger activation of postsynaptic GABAA receptors even 
following inhibition of HLIN activity. Infection efficiency and synaptic localization of 
inhibitory DREADDs will be determined by immunofluorescence for the HA epitope tag 
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(momentum, Adagrad, RMSprop), dropout, KKT conditions.  
• Skills: Java, C++, Python, R, MATLAB, scikit, TensorFlow 
 
Research projects 
2010~current    Johns Hopkins School Of Medicine, Department of Neuroscience  
• Developed and engineered tools to study the function of neuronal circuitry in behaving 
animals 





2012~current    Johns Hopkins University, Department of Computer Science 
• Time Series analysis- developed a state-space model with constrained kalman filter-
based EM algorithm for time series analysis of whole brain activity data (contribution: 
coding and experiments). 
• Deep Learning 1- developed a Caffe-like C++ deep learning package – 
DeepIntelligence, shared on Github, including modules of RNN, LSTM, CNN, RBM, 
AutoEncoder, Multigraph-Reinforcement Learning (contribution: coding and 
experiments). 
• Deep Learning 2- applied and extended deep canonical correlation analysis (DCCA) 
and semi-CCA on a cross-lingual document classification task by learning interlingual 
representations for English and Spanish, improving document classification accuracy by 
5~8% in F1 score. (contribution: code extending and experiments). 
2010~current    Johns Hopkins School of Medicine, Department of Neuroscience  
• Developed and engineered tools to study the function of neuronal circuitry of animal 
behavior 
2009   Rotation Student at Johns Hopkins System Neuroscience 
• Applied a support vector machine classifier (SVM) classifier to successfully tuning 
populational neural decoding patterns from primates somatosentory cortex. 
2007~2009    Research Assistant at Tsinghua University Neural Engieering Lab 
• Conducted memory synchrony analysis in hippocampus firing patterns by phase-
locking signal processing methods.  
 
Education 
2017    Ph.D in Neuroscience. Johns Hopkins School of Medicine - Baltimore, MD  
2015    M.S.E in Computer Sciences. Johns Hopkins University - Baltimore, MD  
2009    M.S.E of Engineering for Robotics. Institute of Automation, Chinese Academy of 
Sciences - Beijing, China. 




1. K. Liu, S. Zhang, J. Kim, DW. Kim, M. Denaxa, HC. Bao, E. Kim, C. Liu, V. Pachinis, 
S. Hattar, J. Song, S. Brown, and S. Blackshaw. Lhx6-positive neurons of the zona 
incerta promote sleep by local inhibition of wake-promoting hypocretin neurons. (Nature, 
under review) 
2. SJ. Chen, K. Liu, YG. Yang, YT. Xu, S. Lee, M. Lindquist, B.S. Caffo, J.T. Vogelstein. 
An M-Estimator for Reduced-Rank System Identification. (Accepted by Pattern 
Recognition Letters) 
3. K. Liu, L. Song, S. Blackshaw, A novel analytic tool to detect contaminants in RNA-
sequencing analysis of FACS-isolated neurons. (submitting to bioRxiv). 
4. K. Liu, KN. Xie, ZM. Qiao, SK. Gao, B. Hong, Impaired neural coordination in 
hippocampus of diabetic rats. Acta physiologica Sinica. 2009,61(5): 417-423. 
5. ZM. Qiao, K. Xie, K. Liu, G. Li, Decreased neuronal bursting and phase synchrony in 






Oral Presentation at the 2nd Annual Johns Hopkins University Sleep and Circadian 
Research Conference, July 27th, 2016.  
K. Liu, S.Zhang, S.Hattar, S.Blackshaw. Hypothalamic Lhx6-positive neurons regulate 
REM sleep. Janelia Conference ‘hypothalamic circuits for control of survival behaviors’, 
Ashburn, VA. Sep 27th~30th, 2015. 
K. Liu, Applications of Semi-supervised CCA and Deep CCA in cross-lingual projection 
for documents classification. 2015 Amazon Graduate Research symposium. 
K. Liu, YG. Yang, SJ. Chen, J.T.Vogelstein. Functional structure analysis of whole brain 
activity by a sparse high dimensional state-space model. Janelia Conference ‘Big data in 
neuroscience: Emerging tools for acquisition and interpretation of whole-brain 
functional data’, Ashburn, VA. Nov, 1st~4th, 2015.  
K. Liu, H. Wang, S. Blackshaw, Control of hypothalamic neuronal specification and 
survival by the LIM homeodomain factor Lhx6. Society for Neuroscience conference, 
Washington DC. Nov. 2014.  
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Leadership 
Chair on Janelia conference ‘hypothalamic circuits for control of survival behaviors’, 
session for Circadian/Sleep-PartIII. Ashburn, VA. Sep 27th~30th, 2015. 
Co-founder and Vice President, Baltimore Chinese A+ Scholar Association. 
Baltimore, MD. Sep 2012 – Oct 2013. 
• Initiated and founded an organization for scientific and social communication among 
visiting scholars and physicians. 
• Organized meetings and social events for over 200 visiting scholars in Baltimore and 
DC area. 
Mentoring, Johns Hopkins School of Medicine. Sep 2009 – present. 
• More than two years mentoring junior postdoc, graduate students and undergrad 
students for neuroscience research in the lab. 
Teaching Assistant, Neuroanatomy course for Johns Hopkins medical students. 
Johns Hopkins University School of Medicine. Feb - Jun 2013. 
 
